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ABSTRACT
The sleep of high anxiety\worry and low
anxiety\worry

subjects were studied by means of nocturnal

polysomnography.

Fifteen high anxiety adult subjects were

chosen to represent an analog Generalized Anxiety Disorder
(GAD) population, and were selected from among individuals
scoring within the upper 20th percentile on the trait
portion of the State-Trait Anxiety Inventory (STAI) and
the Penn State Worry Questionnaire (PSWQ).

Fifteen low

anxiety subjects were selected from among individuals
scoring within the lower 50th percentile on those
measures, and were matched with high anxiety subjects for
age, sex, race, and Beck Depression Inventory (BDI)
scores.

Analysis of polysomnography variables revealed

that high anxiety subjects took longer to fall asleep, had
a smaller percentage of deep (slow-wave) sleep, and a
larger percentage of light transitional sleep (stage 1
NREM) . High anxiety subjects also had more stage 1 NREM
periods, more micro-arousals during the first half of the
sleep period, and a lower REM density relative to low
anxiety subjects.

In addition, high anxiety subjects had

more electrodermal storming when SWS and REM sleep
variables were co-varied.

Results indicated that the

pattern of disruption of sleep depth and continuity was
very similar to that documented in clinical anxiety
disorder patients, and was distinct from that typically

v

shown in depressed patients.

A major implication is that

anxiety and worry are associated with disrupted sleep,
independent of whether or not a diagnosed anxiety disorder
is present.

Current results indicate that these factors

are associated with the sleep disruption observed in
anxiety disorders, independent of the presence of panic,
previous exposure to trauma, or a disease process per se.

vi

INTRODUCTION
Research investigating the inpact of clinical anxiety
disorders and experimental stress paradigms upon EEG sleep
profiles suggest a characteristic disturbance of sleep in
which disruption of the deeper stages of sleep appears to
be primary.

Prior to reviewing this literature, a general

description of the methods and variables typically
utilized in the area of sleep research, as well as a brief
discussion of the general factors influencing sleep
architecture, will be provided.

Research Procedures and Terminology
Experimental studies of human sleep have
characteristically used a procedure referred to as
polysomnography.

Polysomnography is an

electrophysiological recording procedure which utilizes
three standardized measures to characterize sleep:
electroencephalography (EEG) , electrooculography (EOG) ,
and electromyography (EMG) . A standardized scoring
procedure for polysomnography, developed by Rechtschaffen
and Kales in 1968, has been consistently used for both
research and clinical purposes.

Because the variables

discussed throughout the sleep literature make reference
to terms defined by this scoring procedure, a basic
outline of the scoring system and the definitions of
standard the terms will be provided.
1

According to this
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scoring procedure, sleep stages are delineated primarily
by EEG characteristics including relative amounts of alpha
and delta waves, as well as distinctive wave formations
such as K-complexes and sleep spindles.
A waking EEG is characterized by beta and alpha
activity.

Beta activity, which consists of low voltage,

irregular, high frequency waves, represents a state of
arousal and alertness.

Alpha is associated with a state

of relaxed wakefulness, with the eyes closed, and also is
often present in small amounts during transitional sleep
(Stage 1 NREM), the lightest stage of sleep.

Alpha

activity is represented by a relatively synchronous, low
frequency wave (8-12 Hz) of low to moderate voltage.
Delta activity, which is characteristic of the deepest
most restorative sleep, consists of low frequency (1-4
Hz), synchronous, high voltage activity (Carlson, 1986).
Theta activity is not specific to a particular stage of
sleep and may be seen during stages 1 and 2 NREM and REM
sleep.

It is characterized by low frequency (4 to 7 Hz)

low to moderate voltage that may be regular or irregular.
In addition to these characteristic wave forms,
distinctive wave patterns, which include K-complexes and
sleep spindles, are used in sleep scoring.

K-complexes

are defined as high voltage EEG wave forms having a well
delineated negative sharp wave which is immediately
followed by a positive component, with the total duration
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of the complex lasting at least 0.5 seconds (about 3 to 4
Hz).

Sleep spindles are defined by a burst of synchronous

12-14 Hz activity of low to moderate voltage, and must
also be of at least a 0.5 second duration (Rechtschaffen &
Kales, 1968).
In addition to EEG patterns, electrooculographic
(EOG) and electromyographic (EMG) changes are used to
define and measure the five stages of sleep (stages 1 - 4
NREM and stage 1 REM) across a normal night.

EOG channels

provide information about the speed, magnitude and
direction of eye movements from electrodes placed near the
outer canthus of each eye.

EMG recordings provide

information regarding the tonicity of muscles on and
beneath the chin.
These sources of information (EEG, EOG, EMG) are used
to delineate sleep stages in the following manner.

EEG

recordings immediately prior to sleep onset are
characterized by a preponderance of alpha activity and/or
low voltage, mixed frequency EEG activity.

Although not

included within the five sleep stages, this state is
frequently referred to as Stage W in research literature.
Stage 1 NREM is characterized by low voltage, mixed
frequency EEG activity in the 2-7 Hz range in conjunction
with a relative decrease in alpha (less than 50% of the
standard measurement period, 30 seconds) and the presence
of slow movements in the EOG channels.

Stage 2 NREM shows

characteristic EEG patterns of K-complexes and sleep
spindles on a background of relatively low voltage, mixed
frequency EEG activity, while stages 3 and 4 NREM are
defined by the occurrence of high voltage low frequency
delta waves.

REM sleep, which is generally associated

with dreaming, occurs when a stage 1 EEG is present in
conjunction with markedly decreased EMG activity and the
occurrence of rapid eye movements in the EOG channels.
Stages 2-4 NREM are collectively referred to as
synchronous sleep (SS) or NREM sleep by researchers.
These stages are differentiated by visual ratings of the
amounts of high voltage delta (HVD) activity in each EEG
epoch: stage 2 NREM contains little HVD (less than 20%) ,
stage 3 NREM an intermediate amount

(at least 20% butnot

more than 50%), and stage 4 NREM is dominated by HVD
activity (more than 50%) .

Stages 3 and4 NREM are

frequently referred to jointly as slow-wave sleep (SWS) or
delta sleep.

General Factors Influencing Sleep Architecture
Sleep architecture refers to the orderly progression
of stages which occur during an ordinary night's sleep.
The five stages of human sleep alternate in a cyclic
fashion, with periodic episodes of REM sleep occurring at
approximately 90 minute intervals, and with each
successive REM episode getting longer.

In contrast, SWS

Awake

REM

Stage 1

Stage 2

Stage 3

Stage 4

1 sec

Figure 1. Polysomnographic recordings illustrating
wakefulness and sleep stages 1,2,3,4, and REM. Based on
Rechtschaffen & Kales, (1963) A Manual of Standardized
Terminology, Techniques, and Scoring System for Sleep
Stages of Human Sleep Subjects.

episodes becoming successively shorter as the sleep period
progresses.

Thus, SWS is generally confined to the first

half of the night's sleep, and the majority of REM to the
second half (Home, 1976) .
Two primary processes have been found to influence
sleep architecture: circadian rhythmicity and homeostasis
(Borbely, 1982) .

Circadian rhythms refer to the cycles of

approximately 24 hours which govern the majority of
physiological functions in the human body.

Light appears

to be the most important factor in synchronizing
biological cycles, with the suprachiasmatic nucleus of the
hypothalamus acting as the main oscillator, or biological
clock, within the system (Hauri, 1992).

In the context of

sleep, homeostasis (the tendency toward stability in the
normal physiological state of an organism) relates
primarily to SWS.

It is expressed by the preservation of

deeper stages of sleep in restricted sleep paradigms
(Home & Wilkinson, 1985/ Tilley & Wilkinson, 1984) and
the preferential rebound of SWS during recovery sleep
following sleep restriction (Tilley, Donohoe, & Hensby,
1987).
The duration of SWS is primarily influenced by the
length of the prior period of wakefulness.

Following

sleep deprivation, the changes in SWS from baseline levels
during subsequent recovery sleep has been shown to be
directly related to outstanding SWS debt (Tilley et al.,

1987) .

In fact, the remarkable precision of SWS

homeostatic control has led researchers to conclude that
delta sleep is of considerable biological importance
(Feinberg, March, Floyd, Jimison, Bossom-Demitrack & Katz,
1985) , though the nature of that function is currently
uncertain.
In addition to sleep debt, the timing of sleep exerts
an effect upon sleep architecture through the influence of
circadian rhythms.

A major control variable of the

circadian system is body temperature, which has been shown
to drive sleep patterns in the absence of light/dark
cycles (Czeisler et al, 1980).

Sleep onset typically

occurs as the body temperature falls, beginning in the
early evening hours (5-7 pm) and temperature continues to
fall through the mid-morning hours (until 5-7 am) .
Circadian rhythms appear to exert a particularly strong
influence upon REM sleep;

the majority of REM occurs

during mid morning hours which constitute the low point in
the temperature cycle.
In situations where circadian and homeostatic factors
exert conflicting influences, the impact of homeostatic
drive is more powerful in determining sleep architecture.
Although restriction of the sleep period to the first half
of the night results in large losses of stage 2 and REM
sleep, with only a relatively small loss of SWS (Tilley &
Wilkinson, 1984), the response of the sleep system

following this restricted schedule has been found to be
relatively unaffected by the REM and stage 2 NREM debt, or
by the timing of the subsequent sleep period.

Even when

recovery sleep occurred during the second half of the
night, a period in which circadian factors are believed to
be preferentially conducive to REM sleep, the composition
of recovery sleep was primarily determined by SWS debt
(Tilley, 1985).
In conjunction, these findings strongly support the
hypothesis that obtaining a daily quota of SWS acts as the
primary drive mechanism of the sleep system.

In

contrast, the overall amount of REM sleep appears to be
related to the length of the sleep period.

When the sleep

period is extended, absolute amounts of SWS do not
increase and remain concentrated during the early portion
of the sleep period; the additional sleep is composed
primarily of REM and stage 2 (Webb & Agnew, 1970) .

It has

been hypothesized that REM latency is influenced by SWS;
that REM onset occurs only after a sufficient amount of
the drive for deeper sleep is satisfied (Home, 1976) .

Functions of Slow-Wave Sleep
Although substantial research exists suggesting the
importance of obtaining a daily quota of SWS, there is no
universally accepted theory regarding its purpose.
Several theories of the role of SWS have been proposed; it

has been hypothesized to represent a crucial factor in
information processing, as well as in cerebral energy
conservation and physical and mental restitution.
Researchers supporting the role of SWS in information
processing propose a sequential hypothesis in which the
information gathered by the brain during the waking period
is processed during sleep in two main stages, which
correspond with synchronized sleep (SS; SWS) and REM sleep
periods.

Ambrosini, Sadile, Camevale, Mattiaccio, and

Giuditta (1987a; 1987b; 1991a; 1991b), in a series of
studies which investigated the sleep patterns of a group
of rats following exposure to a learning paradigm,
conclude that synchronized sleep fulfills a primary role
in the initial processing of information gathered during
the preceding waking period.

These conclusions were drawn

from observations indicating that the structure of SS was
determined by the nature of the previous waking experience
(rats exposed to a two way active avoidance task vs.
control rats left in home cages) , with the average
duration of SS episodes markedly increased in rats exposed
to the learning paradigm.

Rats that effectively learned

(L) the task were found to differ from non-learning (NL)
rats in the time of appearance and extent of the
increments in the average duration of SS episodes followed
by wakefulness versus SS episodes followed by paradoxical
(REM) sleep.

NL rats showed a greater tendency toward SS-
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W periods, while L rats demonstrated a greater tendency
toward extended SS periods followed by REM sleep.

Based

upon this information, it was suggested that memory traces
lacking adaptive value may be cleared away during SS-W and
SS-REM episodes, while the remaining memory traces may be
retained and eventually stored again in more integrated
form during SS-REM and REM episodes, respectively.
conclusions are problematic in several ways.

These

The failure

of these authors to distinguish between high amplitude SS
(similar to SWS) and lighter stages of NREM sleep limit
the specificity of their findings and may serve to obscure
important differences in NREM sleep structure of postacquisition sleep.

In addition, it appears that there is

an important uncontrolled variable, stress, which may be
reasonably assumed to differ among control, learning, and
non-learning rats; and which could have influenced sleep
architecture.
Other basic animal research investigators have
hypothesized that the decreased levels of mean cerebral
metabolism, and markedly lowered metabolism in the
thalamic sensory relays and cortex during SWS, supports a
role for SWS in cerebral energy conservation (Ramm &
Frost, 1986).

Other theorists have expanded the energy

conservation hypotheses to include restorative functions.
SWS has traditionally been linked to general tissue
restitution, primarily as a result of the increased

synthesis and release of human growth hormone which occurs
during this period (Adams & Oswald, 1977) . However, H o m e
(1983/ 1985) reviewed available research regarding SWS and
general tissue restoration and concluded that there is
little convincing evidence supporting the role of SWS in
this process.

Rather, he proposed that sleep may actually

represent a degenerative period due to the night-time
fast.

In the absence of evidence for a general tissue

restoration hypothesis, it is proposed that SWS more
accurately represents a period of cerebral restitution.
In both animal and human research, SWS consistently has
been found to reflect a degree of lowered cerebral
metabolic activity relative to that found in other states
of consciousness.

In addition, SWS has the appearance of

some form of recovery function, as it is the sleep state
most highly correlated with the length of prior
wakefulness.

H o m e also concludes that only a portion of

sleep seems obligatory, and that this portion is
associated with the SWS present during the first few hours
of the sleep period.
The theory that SWS represents obligatory and
restorative sleep, which is believed to be oriented
towards brain restitution, is consistent with evidence
indicating that obtaining a daily quota of SWS represents
the primary sleep drive.

Other periods of sleep, such as

REM, represent a less primary drive and are thus

12

influenced by other factors such as the timing of the
sleep period.

These secondary sleep functions, which

include both REM sleep and the lighter stages of NREM
sleep (stages 1 & 2), are believed by many theorists to
result from an adaptive, rather than restorative, function
of sleep (Webb, 1988) .

They are proposed to have evolved

as an adaptive behavioral responses associated with
predator/predatee and foraging requirements of the
species.
H o m e 1s hypothesis that SWS represents a period of
cerebral restitution does not contradict the possibility
that SWS is involved in the processing of information
gathered during the waking period.

Thus, although no firm

consensus exists as to the exact function of SWS, the
prevailing theories are not inconsistent with one another.
Failure to obtain sufficient amounts of delta sleep
have been linked to specific decrements in daytime
cognitive performance of healthy subjects.

Partial or

total sleep deprivation has been shown to produce a
significant worsening of performance on vigilance and
reaction time tasks (Bonnet, 1985; 1986b; Downey & Bonnet,
1987; Home, Anderson, & Wilkinson, 1983; Tilley &
Wilkinson, 1984) . H o m e and Wilkinson (1985) attenpted to
determine if the relationship between cognitive
performance and sleep parameters was homogenous or if it
had a specific correlation with a certain sleep parameter.

By reducing the last 2 hours of sleep each night during a
6 week period they were able to decrease stage 2 and REM,
while leaving SWS unmodified.

Under these conditions no

deleterious effect upon daytime vigilance was observed.
Thus, although it seems clear that daytime performance is
affected by sleep deprivation, this decrement does not
appear to occur with selective stage 2 NREM or REM sleep
loss.
In addition, specific decrements in SWS have been
found to be correlated with slowed reaction times in
normal subjects.

When a group of subjects with slow

versus fast reaction times were compared on baseline sleep
EEG measures, subjects with slow reaction times were shown
to have significantly less delta sleep than subjects with
fast reaction times (Jurado, Luna-Villegas, & Buela-Casal,
1989), leading researchers to suggest that attention after
awakening is related specifically to the amount of delta
sleep during the night.

Healthy young subjects deprived

of delta sleep by periodic awakenings have also been shown
to have significant decreases in morning vigilance and nap
latency (Bonnet, 1987), as well as significant increases
in subjective ratings of fatigue and decreases in mood
ratings suggestive of a blunting of emotional responses.
These subjects reported feeling more unhappy, less
friendly, less angry, and less clear-thinking following
SWS deprivation.

In summary, considerable research

evidence suggests that SWS represents the primary drive in
the sleep system; and reduction of SWS has been
demonstrated to have observable effects on behavior and
mood during the subsequent waking period.

This is of

particular interest given that disruption of sleep
architecture and reduction of SWS has been documented to
occur in the presence of environmental stressors, and to
constitute a prominent symptom in the clinical
presentation of many psychiatric disorders.

REVIEW OF LITERATURE
Inpact of Stress on Sleep Profiles
The effect of various stress paradigms on sleep
architecture has received some direct research attention
in both animal and human studies.

Experimental designs

used in these studies have typically differed along two
continua: whether they involve acute or chronic stress and
whether they involve physical or psychological stress.

Transient Stressors
The effects of acute situational anxiety on
polysomnographic measures of human sleep have been
documented across several experimental situations, with
mixed findings.

The pre-sleep viewing of a stressful

film has been associated with an increased number of
arousals from REM sleep and an elevated frequency of REMs
(REM density) during REM periods.

The disruption appeared

to be specific to REM sleep; neither increased frequency
of NREM arousals nor disruption or reduction of SWS were
noted (Baekland, Koulack & Lasky, 1968).

However, this

early evidence of disruption of REM processes by transient
stressors has not received subsequent research support.
For example, significant changes in sleep parameters
were not found among eighteen skydivers undergoing the
voluntary stress of a parachute jump.

Neither novice nor

experienced groups showed disruption of SWS or REM
15
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processes during either the sleep period preceding or
following the jump, suggesting that the anticipatory
anxiety and physiological arousal associated with the jump
did not significantly effect sleep in these individuals
(Beaumaster, Knowles, & MacLean, 1978) . However, these
subjects represent a rather unique group in that they
voluntarily sought the arousal associated with the
parachute jump, a situation with little similarity to that
of individuals experiencing clinical anxiety disorders or
undergoing stressful life events.
Very little sleep research utilizing experimental
paradigms involving exposure to transient stressors has
been published, which may be due to the failure of these
paradigms to produce large enough effects on subsequent
sleep profiles to reach statistical significance.

On the

other hand, this trend may reflect the difficulty of doing
ethical research on the effects of transient stressors
that are of sufficient intensity to produce statistically
significant differences.

However, stronger and more

consistent effects have been shown in subjects involved in
ongoing stressful situations.

Ongoing or Chronic Stressors
Significant decreases in slow-wave sleep (in both
animal and human subjects), as well as disrupted sleep
continuity, have been documented in experimental paradigms

involving ongoing stressors of a more chronic nature.
Decreases in slow-wave sleep (specifically stage 4 sleep)
have been documented in a sample of medical students
undergoing exams (Lester, Burch, & Dossett, 1967).

In

this investigation, 53 healthy subjects spent 10 nights in
the sleep laboratory.

During this 10 day period, sleep

was measured for 3 consecutive nights surrounding 2
independent events (1) a laboratory manipulation designed
to represent a mild acute stressor and (2) a day of
medical exams.

In addition, throughout data acquisition

subjects were interviewed regarding significant events
during the preceding day.

Thus, days containing

fortuitous real-life stress events were identified.

These

real-life stressors and the time period surrounding
medical school exams were associated with the highest
level of self-reported anxiety among subjects, and subject
sleep profiles indicated a decrease in the percentage of
stage 4 NREM sleep and an overall increase in awakenings
as self-reported daytime stress increased.

In addition,

anecdotal information gathered during data acquisition
suggested that subjects undergoing stressors in their
personal lives, which were of a more severe and chronic
nature than those represented by exams or the experimental
manipulation, showed a more severe disruption of sleep EEG
patterns, which was characterized by a complete absence of
SWS.

However, no significant effect on sleep parameters
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were found for the time period surrounding the laboratory
stressor, and the percentage of stage REM sleep showed no
systematic relationship to self-reported stress in any of
the experimental conditions.
Disruption of sleep parameters, most notably SWS
processes and sleep continuity, also has been observed
among both animal and human populations during periods of
ongoing physical and psychological stress.

The effects of

chronic pain on sleep in the rat were investigated by
Landis, Levine, and

Robinson, 1989.

The chronic pain

condition, which involved adjuvant arthritis, was found to
result in an increased sleep latency as well as general
increases in the percentage of time spent awake and in
light sleep.

In addition, a significant decrease from

baseline in the amount of high amplitude NREM sleep (SWS)
was noted in animals following initiation of the chronic
pain condition.

Decreases in the amount of time spent in

deep SWS have also been documented in animal models of
chronic anxiety (Marczynski & Urbancic, 1988).

Rats that

underwent prenatal exposure to diazepam, which produced
enduring postnatal deficits of brain benzodiazepine
receptors, showed both a reduction of time spent in SWS
and an inability to habituate to novel environments such
as the radial arm maze.

The behavior of "high anxiety"

rats in the maze was characterized by numerous fecal
deposits and more frequent than normal errors in working
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memory, factors which are attributed to increased anxiety
secondary to decreased benzodiazepine receptors.

Although

these behaviors within the maze environment suggest the
presence of an animal model of anxiety, the observed
decrements in SWS among "high anxiety" rats may actually
represent a non-specific effect of the experimental
manipulation upon GABA systems associated with SWS, rather
than an "anxiety" effect.
Severe disruption of SWS processes have also been
documented in human populations who have undergone cardiac
surgery.

These patients, who were considered to be

undergoing extreme physical and psychological stress,
displayed a nearly complete suppression of EEG indications
of sleep until the second post-operative night (Anch, Orr,
& Karacan, 1976) . As recovery progressed, SWS remained
suppressed longer than REM sleep.

This pattern appears

particularly noteworthy given the preeminence of the
homeostatic drive for SWS, which would predict a
preferential rebound effect for lost SWS (Tilley et a l .,
1987).

Problematic confounds exist in interpreting data

obtained from this population of critically ill hospital
patients.

For example, it is not clear to what extent

these research subjects were receiving medications, such
as benzodiazepines, which may have contributed to the
suppression of SWS.

In addition, "recovery" of these

patients is not clearly defined.

Physical recovery may
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have progressed, but investigators did not document
psychological recovery.

Patient stress levels may have

remained quite high, thereby contributing to the continued
suppression of SWS.

Acute Physical and Sensory Stressors
In contrast to findings regarding chronic anxiety or
physical stressors, experimental manipulations involving
acute physical or sensory stressors have resulted in
increased duration of SWS during the sleep period
following the stressor, and increased stability of SWS
processes as reflected by a decreased number of stage
changes.

Subjects who were exposed to an acute sensory

stress in the form of increased daytime noise load showed
increases in amount of SWS and in stage 4 NREM stability
during the subsequent nights sleep (Fruhstorfer,
Fruhstorfer, & Grass, 1984; Fruhstorfer, Fruhstorfer,
Grass, Milerski, Sturm, Weismann, & Wiesel 1985;
Fruhstorfer, Pritsch, & Fruhstorfer, 1988).

These authors

interpreted increases in SWS as indicative of an
intensified need for recovery caused by increased central
nervous system strain during waking.
The effects of acute physical stressors appear to be
similar to those of sensory stressors.

Physical stress in

the form of extreme physical exercise has been reported to
enhance subsequent SWS among physically fit subjects.
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When the sleep of athletes completing a 92-km marathon was
measured on 4 successive nights, significant increases in
total sleep time and slow-wave sleep were found during the
three nights following the race, with the most profound
increase in stage 4 NREM sleep occurring during the sleep
period immediately following the event (Shapiro, Bortz,
Mitchell, Bartel, & Jooste, 1981).
Increases in NREM sleep were also observed during an
experiment designed to measure of the effect of an acute
physical stressor on the sleep of infants (Emde, Harmon,
Metcalf, Koenig, & Wagonfeld, 1971).

These authors

investigated the effect of routine circumcision on
subsequent sleep.

Circumcisions, which were performed

without anesthesia in a newborn nursery, were typically
followed by a prolonged NREM sleep period.

A group of

circumcised infants showed increases in NREM sleep from
pre-operative baseline levels, which ranged from 41 to
121%, during the night following the operation.

A control

group of infants, monitored during this same time period,
failed show similar changes from baseline recordings.
Post-circumcision effects on NREM sleep were also
reflected in a shorter latency to the first NREM period,
an increased number of NREM periods, and an increased
number of extended NREM periods.

These authors interpret

this increased tendency toward NREM sleep as fulfilling a
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drive for conservation/withdrawal following exposure to an
acute stressor.

Summary of the Effect of Stress Paradigms upon SWS
When stress is viewed as a broad unitary construct,
overall findings for its effect upon SWS appear somewhat
weak and inconsistent.

However, when stressors are

categorized along an acute vs. chronic continuum, a more
cohesive pattern is evident.

In general, acute physical

or sensory stressors appear to be followed by an increased
tendency toward SWS, while ongoing, chronic physical or
psychological stress (anxiety) is associated with
disrupted SWS.

Thus, individuals with psychiatric

disorders entailing emotional stress may be viewed as
experiencing chronic psychological stress, and would
therefore be expected to experience more consistent
disruption of sleep processes than individuals exposed to
transient stressors.

Polysomnography Profiles of Psychiatric Patients
Disruption of sleep architecture is a robust research
finding for many psychiatric patient populations.
Historically, it is the sleep of patients with affective
disorders that has received the primary focus of research
attention.

Several abnormalities consistently have been

documented in this population, including decreased sleep
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continuity, diminished SWS, and altered REM sleep.
Altered REM sleep findings include shortened latency to
the first REM period, increased amount of REM sleep early
in the night, and increased REM density relative to
matched controls (Benca, Obermeyer, Thisted, & Gillin,
1992; Mendlewicz & Kerkhofs, 1991; Reynolds & Kupfer,
1987).

Of these REM abnormalities, increased REM density

appears to be the most consistent finding among depressed
populations across age ranges (Lauer, Riemann, Wiegand, &
Berber, 1991)
In contrast to the attention focused on sleep in
affective disorder populations, very little research has
been focused on sleep disturbances in anxiety disorder
patients.

When available research is considered, the most

consistent findings across anxiety disorder groups are
disturbed sleep continuity and reduced SWS.

However,

these findings lack specificity and are often noted in
other psychiatric disorders as well, including depression,
schizophrenia, alcoholism, dementia, and insomnia (Benca
et al., 1992).
With the publication of the revised edition of the
diagnostic criteria by the American Psychiatric
Association in 1980 (DSM-III) and 1987 (DSM-III-R) anxiety
disorders have been recognized as independent from
depression, and have received increasing research
attention.

Recent research investigating sleep

disturbances in anxiety disorder patients has focused on
delineating characteristic sleep profiles of individuals
with clinical anxiety disorders such as Post-Traumatic
Stress Disorder (PTSD), Panic Disorder (PD), and
Generalized Anxiety Disorder (GAD).

In addition, there

has been a recent increase in interest in EEG sleep
parameters as promising biological markers for
differentiating primary anxiety vs. depressive
disturbances, and in determining the viability of an
independent diagnostic category of mixed anxiety and
depression (Akiskal, Lemmi, Dickson, King,

Yerevanian, &

Van Valkenberg, 1984; Benca et al., 1992).

A summary of

available research investigating sleep EEG profiles in
anxiety disorder patients will now be provided.

Post-Traumatic Stress Disorder
Sleep disturbance in individuals diagnosed with PTSD
represents the most robust research findings pertaining to
sleep in the anxiety disorders.

Typical sleep EEG

findings for individuals with PTSD include decreased sleep
efficiency (decreased proportion of time asleep while in
bed; increased sleep latency plus time awake after sleep
onset), increased frequency of awakenings,

decreased

amounts of deep restorative sleep (slow wave sleep),
increased amounts of light transitional sleep (stage 1
NREM), increased REM latency, and increased indices of
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autonomic arousal and motor activity (Astrom, Lunde,
Ortmann, Boysen, & Trojaborg, 1989; Glaubman, Mikulincer,
Porat, Wasserman, & Birger, 1990; Kramer & Kinney, 1988;
Mellman, Kulich-Bell, Kumar, & Nolan, 1993; van Kammen,
Christiansen, van Kammen, &

Reynolds, 1990).

Individuals

with PTSD also frequently report the reexperiencing of
traumatic situations in the form of trauma related dreams.
These dreams are unusual in the fact that they occur in
the early portion of the sleep period during non-REM sleep
and are accompanied by great autonomic arousal (Kramer &
Kinney, 1988; van der Kolk, Blitz, Burr, Winthrop, &
Sherry, 1984).

In addition, individuals with PTSD have

been found to show an atypical pattern of nocturnal
arousals:

There is an increased tendency toward arousal

during the early portion of the sleep period, a time that
is normally characterized by deeper stages of sleep and
decreased tendency for arousal among control subjects
(Fuller, Waters & Scott, 1993; Kramer & Kinney, 1988).

Panic Disorder
The available sleep data from individuals diagnosed
with panic disorder is sparse and is plagued by
methodological confounds which limit its value in
clarifying the nature of sleep disturbances specific to
anxiety.

In particular, a high incidence of comorbid
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depressive disorders exists in many of the subjects used
in investigations of sleep in panic disorder (PD).
Individuals with PD but without concomitant
depression have not been found to differ consistently from
normal controls on measures of sleep architecture or
continuity (Dube, Jones, Bell, Davies, Ross & Sitram,
1985) .

In studies which have found significant

differences, lower sleep efficiency (as reflected by
increased sleep onset latency plus decreased total sleep
time) has been noted in comparison to normal controls
(Mellman & Uhde, 1989).

However, methodological problems

limit the usefulness of this data:

In the study by

Mellman and Uhde (1989), eight of the twelve PD patients
reported a previous history of major depression, and six
reported significant depression at the time of the
investigation.
Sleep EEG data from a relatively homogenous sairple of
nine individuals diagnosed as PD with agoraphobia, who
were free from depressive synptoms at the time of
polysomnography, demonstrated increased movement time,
decreased REM latency, and reduced REM density relative to
normal controls (Uhde, Roy-Byrne, Gillin, Mendelson,
Boulenger, Wittone, & Post, 1984).

However, observed REM

latencies were twice the length typically reported in
affective disorder sairples, and were not statistically
different from previously published age norms (Williams et

al., 1974).

Additional data obtained from patients

participating in the study by Uhde and colleagues
indicated significant negative correlations between
measures of global anxiety with both total sleep time and
REM percentage.

In addition, the frequency of panic

attacks was found to be negatively correlated with
percentage of SWS.

Thus, patients with the highest self-

report of global anxiety reported the most frequent panic
attacks and had the shortest total sleep time and lowest
percentages of SWS and REM sleep.
A recent investigation (Stein, Enns, & Kryger, 1993)
sought to alleviate the problematic confounds of co
morbidity with depressive disorders and lack of adequate
control populations.

These researchers compared the sleep

of sixteen patients with PD, who did not currently meet
criteria for major depression, to sixteen, healthy, age
matched, control subjects.

PD patients showed a moderate

reduction in total sleep time and delta sleep relative to
controls, as well as an increased number of stage 1 NREM
episodes.

In addition, a significant negative correlation

was observed between Speilberger Trait anxiety scores and
percentage of SWS.

No other measures of anxiety or

depression correlated significantly with any other sleep
parameter, including any of the measures of sleep
continuity.
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Characteristic sleep patterns have been noted among
individuals who experience nocturnal panic attacks.

These

nocturnal attacks have been found to be relatively
prevalent, with 71% of non-hospitalized PD patients
reporting their occurrence (Roy-Byrne, Mellman, & Uhde,
1988).

Nocturnal panic attacks have been demonstrated to

occur during non-REM sleep and to be associated with
markedly increased autonomic arousal.

In addition, a

tendency toward increased REM latencies has been
documented on nights in which panic occurs (Mellman &
Uhde, 1989).
The frequency of co-morbid depression among
individuals with PD has led some researchers to include
"mixed" groups of PD and depressed individuals (Granhaus,
Rabin, Harel, Greden, Feinberg, & Herman, 1986).

Subjects

with both PD and depression were found to show increased
time to sleep onset as well as disrupted sleep continuity
and decreased sleep efficiency relative to individuals
with only depressive symptoms.

In addition, individuals

in this mixed group have been found to demonstrate REM
latency times which are significantly longer than those
shown by groups diagnosed as major depression without
concomitant anxiety disturbances, and are not
significantly different from REM latency times among
normal individuals (Grundhaus et al., 1986).

Given the current lack of a specific knowledge base
regarding the effect of pure anxiety disorders on sleep
profiles, inclusion of this "mixed" grouping appears
somewhat premature.

Mixed samples have been found to have

a longer duration of illness, increased severity of
symptoms, increased impairment of functioning, and a
higher incidence of co-morbid psychopathology (Dube,
Jones, Bell, Davies, Ross, & Sitaram, 1985), thus
suggesting that differences among mixed groups may
actually represent other non-specific factors.

Generalized Anxiety Disorder
As recently as 1983 a paucity of sleep data existed
on the complaint of generalized anxiety (Rosa, Bonnet, &
Kramer, 1983), reflecting its residual status prior to the
recent publication of DSM-III-R.

Recent studies

addressing sleep EEG findings among psychiatric patients
diagnosed with generalized anxiety disorder (GAD) have
typically conpared these subjects to patient groups with
affective disturbances such as dysthymia or major
depression and/or normal control subjects.
A recent study which investigated sleep patterns
among psychiatric outpatients with the DSM-III-R diagnosis
of GAD found these individuals to have decreased sleep
efficiency, decreased percentage of SWS, and increased
awake time after sleep onset relative to healthy controls

(Arriaga & Paiva, 1990).

However, when patients with GAD

were compared with patients diagnosed with primary
dysthymia, they did not consistently differ on measures of
SWS.

Anxious subjects were found to differ from dysthymic

subjects in that they had less total sleep time and showed
a predominance of awakenings and stage 2 NREM sleep
following initial sleep onset.

Thus, the authors

concluded that although overall reduction of SWS lacked
specificity, it appeared to have different
physiopathologic significance in these two psychiatric
groups:

Among subjects with GAD it seemed to represent an

epiphenomenon resulting from reduction and fragmentation
of sleep, while it was not associated with similar
features of insomnia among dysthymic subjects.
In an uncontrolled investigation which compared
outpatients diagnosed with GAD versus major depressive
disorder (MDD)

(Reynolds, Shaw, Newton, Coble, & Kupfer,

1983), both psychiatric groups demonstrated a pattern of
disrupted sleep when corrpared to previously published age
norms (Williams, Karacan & Hursch, 1974) . Both sets of
subjects showed decreased percentage of SWS and decreased
sleep efficiency, as well as problems initiating and
maintaining sleep which were evidenced by an increased
number of awakenings and increased sleep onset latency.
When compared directly to individuals with major
depression, GAD subjects were found to experience an
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increased amount of intermittent wakefulness, increased
REM latency, and decreased REM percentage and density;
measures of SWS and sleep continuity were not found to
differ between groups.

However, the usefulness of the

results from this investigation is limited by poor subject
selection:

Individuals in the anxious group were also

significantly depressed, and six of the ten anxious
subjects also had concomitant personality or affective
disorders.

This prevalence of co-morbidity among the

anxiety subjects limits the extent to which observed
polysomnography profiles may be considered to reflect
specific anxiety processes.
Similar results were obtained when a group of
inpatients with GAD were compared with inpatients with MDD
and normal control subjects.

GAD patients were found to

have increased sleep latency and decreased total sleep
time relative to control subjects (Papadimitriou,
Kerkhofs, Kempenaers, & Mendlewicz, 1988).

In addition,

these GAD subjects showed significantly longer REM latency
and lower percentage of REM sleep than MDD subjects.
However, contrary to other published research findings
(Arriaga & Paiva, 1990; Reynolds et al., 1983), this
sample of GAD patients showed fewer awakenings during the
sleep period than MDD subjects. Although differences were
not statistically significant, GAD subjects did show a
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lower mean percentage of SWS relative to both MDD and
control groups.
When GAD subjects were compared with a mixed subject
group diagnosed with both MDD and GAD, as well as subjects
with MDD without concomitant anxiety (Papadimitriou,
Linkowski, Kerkhofs, Kempenaers, & Mendlewicz, 1988); no
significant differences in sleep EEG were found between
the mixed group and the GAD group.

The mixed group showed

longer REM latency than the MDD group, with values falling
close to those of GAD patients.

No differences were noted

in percentage of SWS or other measures of sleep
architecture between groups.

However, no control group

was available for comparison.

Mixed Anxiety and Depression
In addition to differences noted in individuals with
clinical anxiety disorders, differences in EEG sleep
profiles have been noted among affective disorder patients
as a function of anxiety level (Akiskal, Lemmi, Dickson,
King, Yerevanian, & van Valkenburg, 1984) . A group of
dysthymic patients with concomitant "anxiety neurosis"
showed significant differences in sleep variables when
compared to general dysthymic patients and a control group
of medically ill patients.

Subjects in the anxious

dysthymic group included individuals with generalized
anxiety disorder and/or panic disorder in conjunction with

chronic dysphoric syrrptoms.

Insomnia was found to be a

prominent presenting complaint among the anxious
dysthymics, while "pure" dysthymics reported a high
incidence of hypersomnia.

In addition, anxious

depressives showed higher degrees of arousal as measured
by a greater number of awakenings and stage shifts than
the other two groups, while dysthymics showed
significantly decreased REM latency.
A recent investigation sought to clarify the effect
of situational anxiety on the sleep of depressed
individuals by examining the effect of severe stress on
the polysomnography profiles of individuals with the
diagnosis of endogenous MDD without co-morbid anxiety
disorders (Monroe, Simmons, & Thase, 1992).

Persons who

had experienced severe stressors shortly before the onset
of depression were found to have essentially normal REM
latency values, while patients without such stress showed
reduced REM latency values.

When the effects of severe

events were statistically removed, and the influence of
increased "life stress" both before and after onset of
depression was assessed, the relationship continued to
hold:

Individuals with high stress levels showed

essentially normal REM latency values.

This data supports

a hypothesis that stress may influence REM latency through
mechanisms other than those which are thought to determine
etiologic differences.

The authors suggest that life

stress prolongs REM latency, thereby approximating normal
values among depressed individuals who would theoretically
have abnormally short REM latencies.

Unfortunately,

reporting of sleep EEG findings in this study was confined
to REM latency values, thus limiting the usefulness of
results in determining the possible mechanism(s) by which
stressors extend REM latency times.

In addition, no

control group of non-depressed individuals was available
for comparison, thus leaving the effect of increased life
stress upon REM latency in individuals without depressive
disorders unclear.

Summary of Psychiatric Findings
In summary, polysomnographic findings across anxiety
populations have been somewhat less consistent than
results obtained from individuals diagnosed with
endogenous depression.

General findings include decreased

SWS and increased REM latency, as well as decreases in
total sleep time, sleep efficiency, and sleep continuity
measures.

Although overall reduction of SWS and

disruption of sleep continuity have not been shown to be
specific to anxiety disorder populations, multiple
research findings suggest that the total amount of SWS, as
well as sleep continuity and duration, are correlated with
measures of clinical severity in anxiety populations, but
are not similarly correlated in affective disorder
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populations (Arriaga, Rosado, & Paiva, 1990; Mellman,
Thomas, & Uhde, 1989; Papdimitrou, Linkowsky, & Kerkhofs,
1988) .
The relation between anxiety and the disruption of
SWS and sleep continuity is further strengthened byresearch findings among non-psychiatric individuals with
high levels of generalized anxiety.

When depression was

held statistically constant in this population, a
significant positive relationship was noted between
anxiety ratings and number of awakenings, and a
significant negative correlation was found between level
of anxiety and amount of SWS (Rosa et al., 1983) . In
contrast, significant correlations were not present
between these sleep parameters and depression ratings.
In addition, these high anxiety individuals showed
disruptions of sleep similar to those documented in
clinical anxiety disorders, with a marked tendency toward
less sleep and lighter sleep.
Additional evidence suggesting that a specific
disruption of sleep continuity is characteristic of
anxiety populations is provided by findings of an atypical
arousal pattern among individuals with PTSD.

However,

this phenomenon has not been investigated in other anxiety
disorder groups, and it is unclear to what extent it may
be limited specifically to individuals previously exposed
to traumatic situations.

In addition, no formal scoring
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criteria for arousals or awakenings was available prior to
the standards published in 1992 (Bonnet et al., 1992), and
this lack of methodological consistency limits the
reliability of previous research results.
The area of polysomnographic research among anxiety
disorder populations contains several other problematic
confounds, including the frequent presence of co-morbid
pathology in anxiety disorder populations (Sanderson,
DiNardo, Rapee, & Barlow, 1990) and the long-standing
nature of the psychiatric disturbance in many such
research subjects (Akiskal et al., 1984; Reynolds et al.,
1983).

These factors call into question the assumption

that it is primarily the anxiety level of the subjects
which accounts for polysomnographic changes noted among
these clinical groups, and necessitate further research on
individuals with "pure" anxiety states which are not
complicated by comorbid psychopathology.

THE PRESENT STUDY
Population of Interest
The purpose of the investigation was to clarify the
nature of sleep disturbance associated with "pure" anxiety
states.

In order to investigate the inpact of anxiety

levels on sleep in individuals without concomitant
psychopathology, a sanple of individuals with an analogue
of generalized anxiety disorder (GAD) was selected from
among undergraduate students at Louisiana State
University.

Generalized Anxiety Disorder has been

characterized as a relatively pure instance of high trait
anxiety (Rapee, 1991).

Age of onset is generally early

and insidious, many individuals report the disorder as
lifelong (Rapee, 1985).

It has been characterized as the

most "normal" anxiety disorder, and it is virtually
inpossible to define a cutoff point quantitatively
distinguishing GAD from normal anxiety (Hoehn-Saric &
MacLeod, 1992).

There does not appear to be a clear

qualitative demarcation distinguishing GADs from non
psychiatric populations with high levels of trait anxiety.
In fact, cognitive differences between GAD subjects and
normals have been found to be much the same as between
normals who are high and normals who are low on measures
of trait anxiety (Eysenck & Mathews, 1987) .

The tendency

to worry, which is the central feature of GAD as defined
by DSM-III-R, also has been found to be highly correlated
37
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with trait anxiety (Borkovec, Robinson, Pruzinske, &
Depree, 1983). In light of the similarities between
individuals with high trait anxiety and those with GAD, an
analog population of individuals with high trait anxiety
was chosen as one that could be appropriately compared to
normal individuals with low trait anxiety.
There is typically a long time between the onset of
GAD (mid-teens) and presentation to a clinical facility,
with an average period of almost 25 years (Rapee, 1991).
During this time there is ample opportunity for the
development of secondary psychopathology, such as
depression, as a consequence of demoralization resulting
from chronic anxiety (Akiskal et al., 1984; Barlow, 1992) .
Thus, by identifying a relatively young subject pool high
in trait anxiety prior to their presentation to a clinical
facility it was hoped that the confounding co-morbidity
present in the psychiatric literature would be avoided.
The trait portion of the State-Trait Anxiety
Inventory (STAI Appendix A) and the Penn State Worry
Questionnaire (PSWQ Appendix B) were used a screening
measures to identify this subject pool.

The STAI is a

frequently used, brief, self-report measure of state and
trait anxiety which has been shown to be of adequate
reliability and validity.

Alpha coefficients for the

trait anxiety component of the instrument range from .90
to .92 (Speilberger, 1983).

Items for the trait portion

of the scale, which was utilized in the present
investigation, were originally selected because they were
highly correlated with the Manifest Anxiety Scale (Taylor,
1951), were stable over time, and were not much affected
by situational stress (Taylor & Amow, 1988) .

In general,

the assumptions of the STAI have been confirmed.

The

STAI-state has been shown to be influenced by situational
factors, while the STAI-trait has shown stable properties.
STAI-trait test-retest reliability coefficients have been
found to range from .76 to .86 across a 20 day delay
(Speilberger, 1983).
The second selection instrument, the PSWQ (Appendix
B), is a recently developed, brief self-report measure
which has been shown to possess high internal consistency
(alpha coefficient = .94) and a test-retest reliability
coefficient of .92 (Meyer, Miller, Metzger, & Borkovec,
1990).

The measure has also been shown to be stable over

periods of 2 weeks (r = .75) and 4 weeks (r = .74), and to
significantly discriminate college satrples who met all,
some, or none of the DSM-III-R criteria for generalized
anxiety disorder.

The PSWQ has also shown discriminant

validity in that it successfully identified GAD from all
other anxiety disorders (Brown, Antony, & Barlow, 1992).
These two selection measures were chosen for their
relative brevity and sensitivity to factors associated
with GAD.

The STAI-trait was included due to its
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widespread use as a research tool and its previous success
in differentiating college samples into high versus low
trait anxiety samples.

Subjects selected by virtue of

STAI-trait scores have shown significant differences in
self-reported sleep patterns as well as measures of whole
blood serotonin content (Davis, Dunlop, Shea, Brittain, &
Hendrie, 1985).

The PSWQ was included for its emphasis on

cognitive factors associated with GAD.

With the advent of

DSM-III-R, etrphasis of diagnostic criteria for GAD has
shifted toward the cognitive component of the disorder,
worry.

Current trends also suggest that pathological

worry (worry perceived as uncontrollable) will become an
essential feature of the
DiNardo, 1991).

DSM-IV criteria (Barlow &

Thus, it was anticipated that through

inclusion of these two measures, a sample would be
identified with the characteristics of high trait anxiety,
as defined in previous research, as well as the cognitive
conponent (worry) which most reliably distinguishes GAD as
a diagnostic entity apart from other anxiety disorders.
High anxiety subjects were chosen from among
individuals scoring within the top 20th percentile of the
screening sample on both the STAI-trait and PSWQ; low
anxiety subjects were chosen from among individuals
scoring within the bottom 50th percentile on these
measures.

Subjects were also administered the Beck Depression
Inventory (BDI Appendix C; Beck, 1978; Beck, Ward,
Mendelson, Mock & Erbaugh, 1961) during initial screening
procedures.

The BDI is the most frequently used self-

report method for assessing level of depression (Shaw,
Vallis,

Sc

McCabe, 1985) .

It has been shown to have

adequate internal consistency (Beck & Steer, 1987;
Reynolds & Gould, 1981), with alpha coefficients of .86
and .81 for psychiatric and non-psychiatric populations,
respectively.

The BDI has also been shown to have

concurrent validity with clinician's ratings of depression
(Beck et al., 1961; Brumberry, Oliver, & McClure, 1978).
Subjects within the high and low anxiety groups were
matched for BDI score (within 2 points) in order to avoid
a difference in level of depression between groups.

In

addition, any subject scoring a BDI of 15 or higher was
excluded from further participation, as this level has
been reported to be indicative of clinically significant
depressive synptoms (Beck & Steer, 1987).
After reading and signing a General Informed Consent
(Appendix D) subjects were also screened orally to rule
out the presence several psychiatric disorders which have
been found to affect sleep, including panic disorder,
PTSD, obsessive conpulsive disorder, major depression,
dysthymia, mania/hypomania, psychosis, and substance
abuse.

The format for this oral screening (Appendix E)
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was based on DSM-III-R diagnostic criteria.

The purpose

of the screening was not formal diagnosis, but to identify
and exclude subjects who may have met diagnostic criteria
for previously listed psychiatric disorders.

Thus,

subjects were excluded if they reported significant
psychiatric symptoms, even if sufficient information was
not present to formulate a definite diagnosis.
Any subjects who reported significant symptoms
suggestive of psychiatric disorders other than GAD were
excluded from further participation.

Subjects were also

screened for the presence of confounding sleep
disturbances by means of the Sleep Disorders Inventory
(SDI; Appendix F) .

Subjects were excluded who endorsed

items consistent with the presence of sleep apnea,
periodic limb movements of sleep, restless leg syndrome,
or various parasomnias (e.g. sleep walking).

Subjects who

reported relying upon alcohol or hypnotic medications to
fall or stay asleep and individuals with irregular sleepwake cycles (eg. shift workers) were also excluded from
participation.

Other exclusion criteria included previous

history of psychiatric treatment and regular use of
illegal drugs or prescription medications known to affect
sleep.
Variables of Interest
Measures of sleep architecture and quality, including
sleep onset latency, REM latency, percentage REM,
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percentage Stage 1 NREM, percentage SWS, total stage
changes, and time awake after sleep onset were of interest
to the present investigation

High anxiety individuals

were expected to show greater disruption of sleep
continuity, increased sleep latencies, more light
transitional sleep, and reduction of SWS.
In addition to these traditional sleep parameters,
micro-arousals (spontaneous transient arousals) during the
first and second halves of the sleep period, number of
stage 1 NREM episodes, and electrodermal activity during
sleep were assessed in an attempt to maximize the
sensitivity of polysomnographic recordings.

Current

researchers encourage the study of sleep micro-structure
to increase the discriminative power of sleep EEG findings
(Arriaga & Paiva, 1990), and it was hoped that inclusion
of these additional parameters would aid in clarifying the
nature of SWS attenuation and sleep continuity disturbance
previously documented among anxiety subjects.
In addition, prior research has lacked
standardization of scoring for arousals.

The present

study utilized recently published standardized criteria
for arousals (Bonnet et al., 1992) to provide a more
reliable index of these events.

These micro-arousals are

of considerable clinical importance, and have been shown
to be equally as disruptive of sleep quality and
restorativeness as full awakenings or movement arousals.
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Periodic micro-arousals have been linked to suppression of
SWS, as well as degraded mood, increased sleepiness, and
decline of performance on vigilance tasks during the
subsequent waking period (Bonnet, 1985; 1986a; 1986b;
1987) .
It was also hypothesized that individuals with high
trait anxiety would show an atypical arousal pattern
similar to that evidenced in PTSD subjects, which is
characterized by a relatively greater number of arousals
during the first half of the sleep period than is seen in
normal control subjects.

In individuals with normal sleep

patterns, spontaneous awakenings from sleep are
hypothesized to reflect the rising phase in the underlying
circadian rhythm during the sleep period (Gillberg &
Akerstedt, 1983) . Early portions of the nocturnal sleep
period are associated with a rapid cooling of the body's
core temperature, a phenomenon which is correlated with
high probability of sleep onset, sleep maintenance, and.
the presence of SWS.

As the core temperature rises during

the latest portions of the nocturnal sleep period, the
probability of arousal becomes much greater and the
likelihood of sleep onset and sleep maintenance is
reduced, even in conditions of sleep deprivation (Gillberg
& Akerstedt, 1983; Webb, 1982).

Thus, spontaneous

arousals tend to occur predominantly during the second
half of the night1s sleep while circadian factors are more
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favorable to awakenings and the lighter stages of sleep
are more prevalent.
Data from previous research investigations (Fuller et
al., 1993; Kramer & Kinney, 1988) have demonstrated a
pattern of arousals in control subjects which is
consistent with this model, and an arousal pattern among
PTSD subjects which is not.

In contrast to control

subjects, who show the expected decreased arousability
during the early portion of the sleep period, individuals
with PTSD show a constant pattern of arousability across
the sleep period, with significantly greater amounts of
disruption during the early portions of the night's sleep.
Kramer and Kinney (1988) proposed that individuals who
have experienced universal trauma, and who are
experiencing acute symptoms, thereafter maintain an
altered physiology which is reflected in a disrupted sleep
rhythm characterized by inappropriately high levels of ANS
activity during the early portion of the night's sleep,
with resulting interruption of SWS processes.

It was of

interest whether this pattern is specific to individuals
who have been exposed to traumatic stimuli and have
subsequently developed PTSD, or whether a similar pattern
of arousals would be observed among non-psychiatric
subjects with high levels of generalized anxiety.
The number of Stage 1 NREM episodes was also of
interest as a measure of sleep continuity and quality.

Brief episodes of Stage 1 NREM appear to reflect decreased
continuity of sleep because they are transitional in
nature and subjects are easily awakened during these
periods.

Because Stage 1 NREM episodes may be very brief

in nature, their relative number is not necessarily
reflected in total Stage 1 NREM percentage (Stein et al,
1993) .
In addition, electrodermal measures were used to
determine whether there was a greater tendency towards
periods of excessive electrodermal activity (EDA) in
highly anxious subjects.

Previous research examining all

night recordings of electrodermal responses have suggested
an increased tendency toward EDA during SWS and decreased
EDA during REM sleep (Koumans, Tursky, & Solomon, 1968) .
These periods of increased spontaneous electrodermal
activity are referred to as electrodermal "storming."
Storming rates have been found to be associated with
spontaneous EDA response rates during waking, which have
been associated with level of anxiety (Taylor & Arnow,
1988).

Storming also appears to be associated with

presleep trait variables:

For exanple, individuals with

high levels of storming have been shown to score higher on
MMPI measures of anxiety and lower on measures of ego
strength than individuals with less nocturnal storming
(McDonald, Shallenberger, Koresko, & Kinzy, 1976).

This phenomenon has also been associated with
increased situational anxiety in a group of medical
students studied by Lester et al. (1967).

These subjects

showed a disruption of sleep architecture during periods
of increased daytime stress, characterized by increased
awakenings and decreased SWS.

In addition, subjects

showed elevations of electrodermal activity during periods
of situational stress.

Electrodermal activity, which is

primarily a SWS phenomenon under normal conditions,
increased in all EEG stages as daytime stress increased.
In contrast, subjects undergoing extreme stressors, who
showed suppression of SWS sleep, showed decreased
electrodermal activity from baseline conditions; thus
suggesting that SWS in a necessary condition for notable
electrodermal activity in the sleeping state.

It was of

interest to the present investigation whether high levels
of trait anxiety were associated with elevations of
storming activity similar to those observed during periods
of situational stress.

Summary and Hypotheses
In summary, the following polysomnography variables
were investigated in the current study: sleep onset
latency, REM latency, percentage of stage 1 NREM,
percentage of SWS, percentage of REM sleep, number of
arousals during the first half of the sleep period, number
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of arousals in the second half of the sleep period, number
of stage changes, time awake after sleep onset, REM
density, number of stage 1 NREM episodes, and percentage
of epochs containing electrodermal storming.

Based on

available research findings, the following hypotheses were
offered regarding variables related to depth of sleep,
sleep continuity, electrodermal activity, and sleep onset:
1. High anxiety subjects were expected to show
greater disruption of sleep continuity as
reflected by higher frequency of micro-arousals,
higher frequency of stage 1 NREM episodes, more
time awake after sleep onset, and a greater number
of stage changes relative to low anxiety subjects.
2. High anxiety subjects were expected to differ from
low anxiety subjects in distribution of arousals
across the

sleep period, with high anxiety

subjects showing a greater frequency of arousals
during the first half of the sleep period.
3. High anxiety subjects were expected to spend a
greater amount of total sleep time in light,
transitional sleep (stage 1 NREM) and less time in
deep restorative sleep (SWS) relative to low
anxiety subjects.
4. High anxiety subjects were expected to show
longer latency to sleep onset relative to low
anxiety subjects.
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5. High anxiety subjects were expected to show higher
levels of electrodermal "storming" relative to low
anxiety subjects.
Research findings regarding the relationship between REM
sleep variables and anxiety is inconsistent, although
these variables have been found to be relevant to
depression.

They were included in the present

investigation in an attempt to clarify their relationship
to "pure" anxiety states.

Although somewhat inconsistent,

available research suggests the following patterns:
6. High anxiety subjects were expected to show
longer REM latency, lower REM density, and lower
REM percentage relative to low anxiety subjects.

METHOD
Subject Selection
Subjects were recruited from among the undergraduate
population at Louisiana State University,

A total of 435

subjects underwent preliminary screening which consisted
of the trait portion of the State-Trait Anxiety Inventory
(STAI-trait) the Penn State Worry Questionnaire (PSWQ) and
the Beck Depression Inventory (BDI) .

The STAI-trait and

the PSWQ, which are designed to measure the related
constructs of trait anxiety and worry, showed a high
positive correlation among the screening sample (r = .683,
p < .001), which was similar to the correlation noted
between these measures (r = .64) by Meyer and colleagues
(1990) in their sample of 386 undergraduates.

Although

significantly correlated, the STAI-Trait and PSWQ shared
only 47% of the variance, which is consistent with
assertions by Meyer and colleagues that the PSWQ measures
the independent construct of worry.
These selection measures also showed low positive
correlations with the BDI in the screening sample: The BDI
correlated .41 and .31 with the STAI-trait and PSWQ,
respectively.

These low, positive correlations likely

reflect the dysphoria (or negative affect) component
shared between generalized anxiety and depression (Clark &
Watson, 1991/ Watson Clark & Carey, 1988).

The

characteristics of the initial screening sample, from
50
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which final subjects were selected, are presented in
Table 1.

STAI-trait scores are expressed in T-scores

while PSWQ and BDI scores are expressed as raw scores.
From this sample, 36 individuals were identified as
appropriate for screening interviews.

High anxiety

subjects were chosen from among individuals scoring within
the upper 20th percentile on both the STAI-trait and the
PSWQ.

Low anxiety subjects were chosen from among

individuals scoring within the lower 50th percentile on
these measures.

BDI scores were used as a matching

variable to assure that groups did not differ on this
measure of depression.

Subjects were matched within 2 BDI

points across groups, and individuals scoring above 15
were excluded from further participation.
During the course of screening, five subjects met
previously defined exclusion criteria and were eliminated
from further participation.

Subjects scoring within the

appropriate ranges on the STAI-trait, PSWQ, and BDI, and
who did not meet exclusion criteria, were scheduled to
complete one night of polysomnography at the Baton Rouge
General Medical Center.
polysomnography.

Thirty-one subjects underwent

Subject groups were equated for age

(+/- 3 years), race, and sex to avoid possible confounds.
One subject was excluded prior to data analysis due to
inability to recruit an age-matched subject in the other
group.

The final sample consisted of 15 subjects per
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Table 1.

Characteristics of Screening Sample (n = 435).

Measure

Mean

Standard Deviation

STAI-trait

52.2

11.0

PSWQ

46.7

14.9

7.5

6.2

BDI
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group; each group contained seven males, eight females,
thirteen Caucasian and two African-American students.
Additional sample characteristics are described in
Table 2.
Subjects were instructed not to nap during normal
waking hours and to rise by 8:00 am on the day of
polysomnography.

They were also instructed to abstain

from alcoholic beverages 24 hours prior to sleep
recordings, and not to consume caffeine after 6pm on the
scheduled date of polysomnography.

All subjects reported

that they had been compliant with these instructions.

Hospital Procedures
Prior to scheduling of polysomnography the procedure
was fully explained to subjects (Appendix G) .

Upon

arrival at the sleep laboratory subjects were asked to
read and sign an informed consent for polysomnography
(Appendix H ) . A standard polysomnographic hookup, which
is fully described in Appendix I, was performed according
the montage presented in Appendix J.

Subjects slept in a

private room in the sleep laboratory of the Baton Rouge
General Medical Center.

A research assistant was present

to monitor them from an adjacent control room throughout
the night.

All recordings were made on a Grass

Electroencephalograph Model 8-16 D.

All subjects arrived
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Table 2.

Characteristics of Final Subject Sarrple

(n = 30) .

Mean

Measure

Standard Deviation

High Anxiety Subjects:
Age

24.1

(9.1)

STAI-trait

71.4

(3.8)

PSWQ

61.3

(15.7)

7.9

(2.6)

Age

24.8

(9.2)

STAI-trait

43.4

(5.0)

PSWQ

30.6

(8.8)

7.1

(2.6)

BDI

H(D

s

BDI
Subjects:
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at the laboratory prior to 21:00, and hookup procedures
were completed by 22:30.
Subjects were awakened by 06:30, the electrodes were
removed, and they were instructed to dress for the day.
Subjects then conpleted a sleep diary (Appendix K) in
order to determine a subjective rating of his/her sleep
quality during the recording period, and were given extra
credit vouchers.

If a subject had any remaining questions

regarding the procedure they were answered at this time.

Scoring
Analysis and scoring of the polysomnographic records
followed Rechtsaffen and Kales'
for human subjects.

(1968) standardized method

Of the 30 research records, 10 were

scored independently by 2 individuals experienced in the
scoring of polysomnography records.

These scorers were

found to have adequate inter-rater reliability; the
average percent agreement between independent scorers was
92.7% (standard deviation = 2.4%, range of 88.2% to 95.7%
agreement). Scoring of micro-arousals followed the recent
standardized guidelines described by Bonnet et al. (1992),
which are fully described in Appendix L.

RESULTS
Variables of interest were defined in the following
manner:

Sleep onset was defined by the number of minutes

between lights-out and initial presence of stage 2 NREM
sleep.

Micro-arousals were defined according to ASDA

criteria as presented in Appendix L, and summed separately
for the first and second halves of the sleep period.

REM

latency was determined by the number of minutes between
sleep onset and initial presence of REM sleep.

REM

density was determined by dividing the number of observed
rapid eye movements by the total minutes spent in REM
sleep.

Time awake after sleep onset was defined the

number of minutes of wake time following sleep onset.
Number of stage 1 NREM epochs was determined by counting
the number of independent stage 1 NREM
dividing by the total hours of sleep.

episodes

and

Number of stage

changes was determined by counting the total number of
stage changes and dividing by the total hours of sleep.
Percentage of electrodermal storming (EDS) epochs was
determined by dividing the total number of epochs which
contained storming activity by the total number of sleep
epochs.

Percentages of stage 1 NREM, SWS, and REM sleep

were determined by dividing the total amount of time in
each of these stages by the subject's total sleep time.
Grand means and standard deviations on these
of interest are provided in Table 3.
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12 variables
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Table 3. Grand means and standard deviations for the total
subject sattple (n = 30) on the 12 dependent variables.
Variable

Grand Mean

Sleep Onset Latency

35.03 minutes

Percentage SWS

17.75%

Number of Stage 1 NREM Periods
Arousals (first half)

4.59/hour sleep
30.87 total

Standard
Deviation
(26.26)
(7.54)
(1.53)
(16.32)

REM Density

2.93/minute REM

(1.23)

Percentage Stage 1 NREM

9.29%

(5.10)

Percentage REM Sleep

17.79%

(6.04)

Time Awake After Sleep Onset

30.23 minutes

Number of Stage Changes

18.15/hour sleep

Percentage Storming

36.57% sleep epochs (20.03)

REM Latency
Arousals (second half)

111.95 minutes
27.73 total

(25.02)
(5.42)

(53.14)
(11.29)

Among the 12 dependent variables, significant
correlations were present between the number of arousals
during the first half of the sleep period and five other
variables: percentage of SWS (r = -.50), percentage of
stage 1 NREM sleep (r = .73), number of stage changes
(r = .57), number of arousals during the second half of
the sleep period (r = .56), and number of stage NREM 1
episodes (r = .64) .

Ihe number of stage 1 NREM episodes

was correlated significantly with three additional
variables: percentage of SWS (r = -.47), time awake after
sleep onset (r = .52), and number of stage changes (r =
.60).

A significant negative correlation (r = .-53) was

also present between percentage of REM sleep and REM
latency, in which subjects with longer REM latency showed
a lower percentage of REM sleep.

A conplete listing of

correlations among dependent variables is provided in
Table 4.
The data set was screened for possible outliers
within groups.

Univariate and Multivariate screenings

were performed through separate within group comparisons
for high and low anxiety groups.

Initial data screening

revealed the presence of one variable, number of stage 1
NREM episodes, which contained two values representing
univariate outliers.

These data points fell more than

three standard deviations above the high anxiety group
mean for two subjects in the high-anxiety group.

To
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Table 4. Correlations between dependent variables for
entire subject sample (n = 30; * = p < .01,
** = p < .001).

NREM1%

sws% REM% Onset REML AR1

NR£M1% 1.0

-.43

SWS%

1.0

-.28

.03

■-.16 -.35

AR2 TimeW #Chgs Storm #NREM1 REMD

.17 .73**

.33

.22

.36

.05 -..50* -.06 - .40 - .16

REM%

1.0 - .22 - .53*-..02

Onset

1.0 -.04

.14

REML

1.0 --.03

AR 1

1.0

.08 -.32 -.06
-.21

AR 2

.36

.13
-.04

.26

.19

.08

.45

.29

.13

.56* .23

.57

-.08

.34
.44

1.0

#Chgs

1.0

-.09
.09

.26

1.0 -.04

.46
.47*

.34

-.09

TimeW

.15

-.26

.11
-.07
-.01

Storm

1.0

#NREM1

.15

-.14

.64** -.03
.42
.52*

.30
-.07

.60** - .14
-.00
1.0

REMD

.24
- .10
1.0

KEY
NREM1%

=percentage stage 1 NREM

SWS%

= percentage SWS

REM%

=percentage REM

Onset = sleep onset latency

TimeW

=time awake after sleep onset

REML

= REM Latency

Storm

=percentage of storming epochs

REMD

= REM density.

#Chgs

=number of stage changes per hour sleep

#NREM1

=number of stage 1 NREM episodes

AR1

=number of arousals in first half of sleepperiod

AR2

=number of arousals in second half of sleep period

eliminate the potential irrpact of extreme values during
data analysis, these values were removed and group means
were substituted for missing values.

No other univariate

outliers were identified, and no missing data was present
within the data set.

No within group multivariate

outliers were identified as determined by examination of
Mahalanobi's distance (p < .001); and evaluation of
assumptions of normality, linearity, homogeneity of
variance-covariance matrices, and multicollinearity
revealed no threat of Type 1 error inflation during
multivariate analysis.
A between-groups multivariate analysis of variance
(MANOVA) was used for initial analysis, and the 12
dependent variables were entered into the model
simultaneously.

With the use of Wilks' criterion, the

high and low anxiety groups were found to differ
significantly on the combined dependent variables,
F(12,17) = 5.34, pc.OOl.

Means and standard deviations

for these variables are provided in Table 5.
Significant differences (Univariate F-tests) between
subject group means suggested that high anxiety subjects
took longer to fall asleep (longer sleep onset latency)
and had lighter sleep (lower SWS percentage and greater
percentage Stage 1 NREM sleep) which was more prone to
arousal, especially during the first half of the sleep
period (more arousals during the first half of the sleep
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period and higher number of stage 1 NREM episodes).

In

addition, high anxiety subjects showed a significantly
lower REM density, as well as non-significant trends
towards less REM sleep and more time awake after sleep
onset.

Univariate F-tests for dependent variables are

provided in Table 6.
A direct discriminant function analysis (DFA) was
then utilized to determine to what extent group membership
(high versus low anxiety group) could be determined using
objective polysomnography variables as predictors.

A

significant discriminant function was identified (pi <
.001) which accounted for 79.01% of the variance between
groups on the 12 dependant polysomnography variables.
When the rule of thumb (r > .30) for interpretation
suggested by Tabachnick and Fidell (1989) was applied,
pooled within groups correlations between discriminating
variables and canonical discriminant function (Table 7)
indicated that high anxiety subjects could be reliability
identified to show the following sleep pattern:

They took

longer to fall asleep, had less SWS, and more frequent
stage 1 NREM episodes.
Results of DFA classification procedure for the total
sample of 30 subjects indicated that 29 (96.67%) were
classified correctly.

All high anxiety subjects and 14 of

15 low anxiety subjects were correctly classified, while
one low anxiety subject was classified with the high

anxiety group.

The generalizability of this

classification procedure is limited due to the fact that
the relatively small sample size did not allow for a
cross-validation to be performed, possibly leading to an
artificially inflated classification rate.

However, the

primary purpose of the classification procedure in the
current investigation was not classification, but rather
to determine the consistency of sleep pattern across
subjects.

Results of the classification procedure did

show that the discriminant function reliably distinguished
among individuals across the entire subject sample.

Thus,

a frequent methodological criticism of psychiatric sleep
research, that a few subjects account for the majority of
the variance between groups (Anch, Browman, Mi tier, &
Walsh, 1988) , does not apply to the current
classification.
Arousal patterns were further investigated through a
repeated measures analysis of variance to determine if the
two groups differed in their pattern of arousals across
the sleep period (i.e. first half verses second half of
the sleep period).

Results indicated that groups did not

differ significantly in overall number of arousals
[F(1 ,28) = 2.09, p = .16], but a significant interaction
[F(l,28) = 9.76, pc.Ol] was present between group and
distribution of arousals across the first versus second
halves of the sleep period.
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Table 5. Means and standard deviations for high and low
anxiety subjects on polysomnography dependent variables
(* = p , .05; ** = p < .01).

Variable

High Anxiety
Group
51.03 minutes
(13.51)

** Sleep Onset Latency

Low Anxiety
Group
19.03 minutes
(12.13)

** Percentage SWS

13.51%
(7.12)

21.98%
(5.34)

** Number of Stage 1 NREM Periods

5.41/hour sleep
(1.32)

3.78/hour sleep
(1.29)

* Arousals (first half)
* REM Density

37.47 total
(18.52)
2.43/minute REM
(.85)

24.27 total
(10.72)
3.42/minute REM
(1-37)

* Percentage Stage 1 NREM

11.19%
(5.93)

7.39%
(3.30)

Percentage REM Sleep

15.86%
(5.46)

19.27%
(6.16)

Time Awake After Sleep Onset
Number of Stage Changes

37.63 minutes
(31.89)
19.10/hour sleep
(5.92)

22.83 minutes
(12.73)
17.21/hour sleep
(4.89)

Percentage Storming

9.85% epochs
(21.47)

33.30 epochs
(18.63)

REM Latency

115.23 minutes
(54.12)

108.67 minutes
(53.83)

Arousals

27.47 total
(10.95)

28.00 total
(11.99)

(second half)
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Table 6. Univariate F-tests with (1,28) degrees of
freedom.

Variable

Univariate F
Value

Univariate
Significance of F

Sleep Onset Latency

17.45

.000

Percentage SWS

13.57

.001

# Stage 1 NREM periods

11.64

.002

Arousals (first half)

5.70

.024

REM Density

5.65

.024

Percentage Stage 1 NREM

4.69

.039

Percentage REM Sleep

3.31

.079

Time Awake After Onset

2.79

.106

Number of Stage Changes

.91

.348

Percentage Storming

.80

.380

REM Latency

.11

.741

Arousals (second half)

.02

.900
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Table 7. Pooled within groups correlations between
discriminating variables and canonical discriminant
function.
Variable
*Sleep Onset Latency
*Percentage SWS

Correlation
.40683
-.35865

*# NREM1 episodes

.33214

Arousals (first half)

.23260

REM Density
Percentage Stage 1 NREM
Percentage REM Sleep

-.23163
.21092
-.17727

Time Awake After Sleep Onset

.16253

Number of Stage Changes

.09286

Percentage Storming

.08691

REM Latency

.03244

Arousals (second half)

-.01239

As illustrated in Figure 2, subjects in the high
anxiety group had a higher mean level of arousals during
the first half of the sleep period than the low anxiety
group, while both groups had a similar mean number of
arousals during the second half of the sleep period.
During the first half of the sleep period, high anxiety
subjects showed a mean of 37.47 arousals compared to the
mean of 24.27 for low anxiety subjects.

During the second

half of the sleep period, the low anxiety subjects had a
mean of 28.00 arousals and the high anxiety subjects had a
mean of 27.27 arousals.
In order to clarify the interpretation of
polysomnography dependent variables, the groups were
conpared on additional objective sleep parameters and
subjective sleep estimates.

Evaluation of this additional

data revealed that high anxiety and low anxiety groups did
not differ in total amount of bed time or total sleep
time.

Thus, observed differences in dependent variables

were not attributable to differences in opportunity for
sleep or total amount of sleep obtained.
Estimates of subjective sleep quality were obtained
from subjects' responses on the Daily Sleep Diary
(Appendix K) which they filled out on the morning
following polysomnography.

Numerical values for

subjective sleep quality were obtained by summing
questions seven (Rate the quality of last night's sleep),
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Number of Arousals

40 -35 --

25 -20

- -

First
Half

Second
Half

x------------------- x High Anxiety Group
o------------------- o Low Anxiety Group

Figure 2. Mean number of arousals across the first and
second halves of the sleep period for high and low anxiety
subjects.

and six (How rested do you feel this morning?)

Numerical

values for subjective estimates of difficulty falling
asleep represent the sum of responses from questions five
(How difficult was it for you to fall asleep last night?),
eight (What was your level of physical tension when you
went to bed last night?), and nine (Rate your level of
mental activity when you went to bed last night) .
Subjects were asked to rate their sleep during the night
of polysomnography in comparison to their sleep at home on
a "typical" night.

Subjects responded on five-point

Likert scales with higher numbers representing poorer
perceived sleep quality and increased difficulty falling
asleep.

The reliability of these subjective measures were

evaluated through the use of Chronbach's Alpha. Alpha
coefficients were .80 for measures of sleep onset
difficulty (questions #6 and #7; Appendix K) and .81 for
subjective measures of sleep quality (questions #5, #8,
and #9; Appendix K) .

Thus, these subjective measures

appear to be adequately reliable.

Subject groups did not

differ in either of these subjective measures of sleep;
both groups responded with mid-range likert scores,
suggesting that the sleep that they obtained in the
laboratory was neither markedly good or poor relative to a
"typical" nights sleep.

Means and standard deviations for

these general measures are provided in Table 8.
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Table 8. Means and standard deviations for general sleep
parameters and subjective estimates.
Variable
Total Time in Bed
Total Sleep Time
minutes

High Anxiety
Group

Low Anxiety
Group

7.35 hours
(.39)

7.36 hours
(.53)

353.23 minutes
(50.06)

371.51
(107.77)

Subjective Sleep Quality

5.66
(1.59)

5.60
(1.88)

Subjective Onset Difficulty

8.20
(2.48)

7.47
(2.48)

DISCUSSION
The current investigation found significant
differences in several objective polysomnography variables
between a group of high anxiety subjects, who were chosen
to represent an analog GAD population, and a group of
matched control subjects with lower anxiety levels.
Discriminant function analysis indicated that the two
subject groups could be differentiated by a discriminant
function (97%) in which high anxiety subjects were
reliability identified as taking longer to fall asleep,
having less SWS, and showing more frequent stage 1 NREM
episodes.

MANOVA and follow-up ANOVA indicated that, in

addition, high anxiety subjects showed a significantly
higher frequency of arousals during the first half of the
sleep period, lower REM density, and a higher percentage
of stage 1 NREM sleep.
In general, these results suggest that healthy
individuals with high levels of generalized anxiety and
worry, and without other psychiatric co-morbidity,
experience a pattern of sleep disruption that is very
similar to what has been documented in clinical anxiety
disorders, and which is quite distinct from what has been
observed among individuals experiencing dysthymia and/or
major depression.

Hypotheses based on research data from

studies using generalized anxiety disorder subjects
(Arriaga & Paiva, 1990/ Papadimitriou et al, 1988;
70

Reynolds et al, 1983), which predicted greater latency to
sleep onset (Hypothesis 4), lighter sleep (Hypothesis 3),
and disruption of sleep continuity (Hypothesis 1) , were
supported.

High anxiety subjects showed longer sleep

latency and less deep sleep as reflected in less SWS and
more light transitional sleep (stage 1 NREM).

Disruption

of sleep continuity in the high anxiety subjects was
indicated both by a greater number of episodes of light
transitional sleep throughout the night and by more
transient arousals from sleep (micro-arousals) during the
first half of the sleep period.
In addition, the pattern of micro-arousals across the
sleep period in high anxiety subjects was found to differ
from low anxiety subjects in a manner which supported
Hypothesis 2, and was consistent with previous research
findings in clinical samples suffering from Post-Traumatic
Stress Disorder (Fuller, Waters, & Scott, in press; Kramer
& Kinney, 1988) : The high anxiety subjects, like PTSD
subjects, showed a greater arousability during the first
half of the sleep period relative to low anxiety subjects
and normal controls.

This finding suggests that the

observed pattern of micro-arousals in individuals with
PTSD is likely to be a function of the elevated baseline
anxiety (and perhaps worry) prevalent in the PTSD
population, and is not specific to individuals who have
been previously exposed to a traumatic event.
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This shared component of elevated baseline
anxiety/worry may also account for other (PSG) findings
that were common to both PTSD patients and analog GAD
subjects in the present investigation.

In addition to

increased arousability during the first half of the sleep
period, both satrples had low sleep efficiency (longer
sleep latency and time awake after sleep onset), lower
amounts of deep restorative sleep (SWS), and more light
transitional sleep (stage 1 NREM)

(Astrom et al, 1989;

Fuller et al, in press; Glaubman et al, 1990; Kramer &
Kinney, 1988; Mellman et al, 1993; van Kammen et al,
1990).
Results of the present investigation are also
generally consistent with recent research findings from a
sample of panic disorder (PD) patients who were relatively
free of co-morbidity (Stein et al., 1993).

These panic

disorder patients showed a significantly higher number of
stage 1 NREM episodes and less SWS relative to matched
controls, and their sleep disturbance was most pronounced
during the first half of the sleep period.

Thus, it

appears that the pattern of disrupted sleep continuity and
disturbed depth of sleep shown by the analog GAD subjects
in the current investigation is consistent with findings
among clinical research samples including GAD, PTSD,
and PD.

The lack of sleep depth (low percentage of SWS and
high percentage of stage 1 NREM) and disruption of sleep
continuity observed during the current investigation were
also generally consistent with previous research
investigating sleep parameters among non-clinical
populations with high trait anxiety (Rosa et al, 1983) and
in human and animal populations exposed to chronic,
ongoing stressors (Anch, Orr and Karacan, 1976; Landis et
al., 1989; Lester, et al, 1967; Marczynski & Urbancic,
1988).

However, subjects in the current investigation did

not show the significant mean increase in electrodermal
activity predicted in Hypothesis 5 which has been
previously noted among individuals exposed to the ongoing
stress of medical school exams (Lester et al, 1967), nor
did they show the low levels of electrodermal storming
previously observed among individuals with chronic PTSD
(Fuller et al, in press).
Thus, results of the current investigation failed to
directly clarify the apparently complex relationship
between chronic anxiety states, situational stressors, and
electrodermal activity during sleep.

However, hints about

this relationship were provided when data from the current
study were subjected to an additional analysis in which
SWS percentage, REM percentage, and REM density were covaried to remove their theorized influence on
electrodermal storming (EDS).

In the context of normal sleep, EDS activity occurs
primarily during SWS (Koumans et al, 1968) .

Therefore, it

was hypothesized that individual differences in the amount
of SWS may have affected the "window of opportunity" for
EDS activity.

Previous research has also shown that EDS

is rare in REM sleep (Koumans et al, 1968; McDonald et
al., 1976), probably due to inhibited thermoregulation
during REM sleep.

Therefore, the impact of individual

differences in the prominence of REM sleep (as measured by
the percentage of REM and REM density) were also seen as
possible confounding variables effecting the "window of
opportunity" for electrodermal activity.
In order to control for the hypothesized effects of
these variables on EDS activity, the percentage of SWS,
REM sleep percentage, and REM density were entered as covariates in a hierarchial MANOVA framework.

When these

variables were co-varied, stepwise analyses indicated that
the percentage of storming assumed a significant value
(Roy-Bargmann Stepdown F (1,25) = 7.61, p < .01), with
high anxiety subjects showing a significantly greater
percentage of storming epochs.

These findings indicate

that the relation between electrodermal storming and
anxiety is complex, as it is affected by the degree of
both SWS and REM sleep.
The present findings, that high anxiety subjects had
more electrodermal storming and less SWS than low anxiety

subjects, is consistent with previous research findings
which indicate that, among healthy young adults, anxiety
states both decrease the amount of SWS observed during
polysomnography and increase storming activity (Lester et
al., 1967).

However, the relationship between anxiety,

EDS, and REM sleep variables among subjects in the current
investigation is less clear.

Although the mean percentage

of REM sleep the high anxiety subjects was smaller than
for the low anxiety groups, the groups were not
statistically different on this measure.

High anxiety

subjects did show a significantly lower REM density, which
is suggestive of less sleep satiation (Aserinsky, 1969;
1971; 1973).

These findingssuggest that,

for high

anxiety subjects as a group, REM sleep was somewhat less
prominent in their sleep architecture. Given its
importance as a co-variate, REM percentage, though not
significantly lower for high anxiety subjects, still
exerted influences on EDS.

Thus, the results of the

current investigation provide possible clues to the
relation between anxiety and nocturnal electrodermal
storming activity, an apparently complex interaction
between EDS activity, SWS percentage, REM percentage, and
REM density.

However, the exact relationship between

trait anxiety and EDS activity requires further
investigation.
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In attempting to clarify the inpact of trait anxiety
upon sleep architecture, the pattern of correlations
between dependent variables in the current investigation
is of theoretical interest.

The number of arousals during

the first half of the sleep period was positively
correlated with several variables, including the number of
stage 1 NREM periods, percentage of stage 1 NREM sleep,
and number of stage changes.

It appeared that increased

early arousals were associated with more frequent overall
stage changes, and specifically with shifts into light,
transitional sleep; and that such shifts were associated
with overall increases in percentage of the sleep period
spent in light sleep.

In contrast, both the number of

arousals during the first half of the sleep period and the
number of shifts into light, transitional sleep were
negatively correlated with the percentage of the sleep
period spent in deep, restorative sleep (SWS).
These patterns strongly suggest a relation between
repeated arousals during the early portions of the sleep
period and less sleep depth (more light sleep and less
SWS) . However, due to the correlational nature of
findings, it can not be determined to what extent either
increased early arousability or decreased SWS is the
causal element in this relation, or whether a third
underlying mechanism is accounting for the observed
relations.

However, as these variables also were found to

differ between high and low anxiety/worry subjects who
were otherwise equivalent, the anxiety/worry variable
appears to have explanatory power.

Anxiety level may

account for observed polysomnography (PSG) findings
indirectly through the reduction of sleep depth (less SWS,
more stage 1 NREM), permitting arousals by external
stimuli which would not arouse individuals in deeper
stages of sleep.

Conversely, anxiety level may have acted

to increase arousability directly, especially during the
first half of the sleep period, via the direct inhibition
SWS and a congruent increase in stage 1 NREM.
Previous research has indicated that increased
arousals may represent the causal factor in observed PSG
findings; micro-arousals produced by external stimuli
during the nocturnal sleep period have been demonstrated
to result in suppression of SWS, as well as degraded mood
and increased sleepiness upon awakening (Bonnet, 1985;
1986a; 1986b; 1987).

However, further research is needed

to clarify possible causal links between reduced SWS and
increased arousability during the first half of the sleep
period, and to determine to what extent relations between
these variables may be specific to anxious samples.

In

answering these questions it would be inportant to
investigate whether similar relations are present in
groups of individuals defined by other variables
associated with SWS decrements; such as age, depression,
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or schizophrenia (Benca et al., 1992; Williams et al.,
1974), or whether they are specific to anxious
individuals.
The current investigation failed to find significant
differences between high and low anxiety groups in REM
latency or percentage of REM sleep (Hypothesis 6),
variables which have been highly inconsistent in anxiety
disorder samples, but which have been observed to differ
consistently between depressed patients and controls.

REM

sleep abnormalities which typically have been observed in
depressed samples include shortened latency to the first
REM period and increased REM percentage, especially during
early portions of the sleep period (Benca et al., 1992;
Reynolds & Kupfer, 1987).

Failure of the current

investigation to find reliable evidence of differences in
these variables between "pure" samples of healthy young
adults with high versus low trait anxiety suggest that
previous inconsistent research findings may have been a
reflection of co-morbidity confounds among psychiatric
subjects; specifically, depression in anxiety disorder
patients acting to decrease REM latency and increase REM
percentage and density.
However, Hypothesis 6 was supported in that a
significant difference between groups in REM density was
found.

Research findings in depressed samples have also

consistently found increased REM density relative to

matched controls (Benca, Obermeyer, Thisted, & Gillin,
1992; Mendlewicz & Kerkhofs, 1991; Reynolds & Kupfer,
1987).

REM density appears to represent the most robust

biological marker, across age ranges, differentiating the
sleep of depressed individuals relative to anxious and
normal control subjects (Lauer Riemann, Wiegand, & Berber,
1991).

Differences in REM density were observed in the

current investigation, with high anxiety subjects showing
a lower REM density.

This result is consistent with

previous research findings in panic disorder patients
(Uhde, et al., 1984), and is opposite of the pattern which
characterizes depressed individuals.
REM density has been hypothesized to be an indication
of sleep satiation, with greater REM density indicating
higher levels of satiation.

In studies of healthy young

adults permitted to sleep to their fullest capacity, REM
density has been found to increase throughout the sleep
period (Aserinsky, 1968; 1971; 1973), reaching its maximal
capacity at 7.5 to 10 hours.

Furthermore, when subjects

were studied continuously across a 54 hour period, prior
sleep was found to be positively correlated with REM
density, whereas the length of previous waking period was
negatively correlated (Aserinsky, 1973) . When viewed in
this context, the significantly lower REM density found in
the high anxiety group may be considered an indication
that these subjects have not reached a level of sleep

satiety equal to that of the less anxious subject group.
This explanation is consistent with research indicating
that more anxious individuals tend both to report
preferring to sleep for longer periods of time (McCann &
Stewin, 1987) and to show evidence of increased daytime
sleepiness (Roehrs, Timms, Zwghuizen-Doorenbos, Buzenski,
& Roth, 1990) relative to less anxious control subjects.
Thus, the observed differences in REM density between
groups appears to reflect decreased sleep satiation in
high anxiety subjects, which is likely a function of the
decreased sleep depth and continuity also documented in
polysomnography findings.
The present investigation failed to find significant
differences between high and low anxiety groups in overall
number of stage changes or in total time awake after sleep
onset.

These measures appear to have been less sensitive

than other measures included in the analysis.

The number

of stage changes, which reflected both shifts into lighter
and deeper stages of sleep, appeared to be less sensitive
to differences in anxiety levels than a measure that
represented only shifts into light, transitional sleep
(number of stage 1 NREM episodes).

In a similar manner,

the number of waking epochs appeared to be less sensitive
to differences in anxiety level than the prevalence of
micro-arousals early in the sleep period and the number of
stage 1 NREM episodes.

This suggests that it was the
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disruption of sleep micro-structure, rather than the time
spent consciously awake, that was influenced by anxiety.
The finding that the two groups did not differ in
subjective self-report measures of sleep quality was
unexpected given the significant differences found between
the groups in objective PSG measures of sleep depth and
continuity.

This contradiction between objective and

subjective measures appears to have resulted from the
method used to assess subjective sleep quality, in which
subjects were asked to compare how they slept in the
laboratory to a "typical" night of sleep for them.
Subjects who felt that they "typically" slept badly may
have given subjective estimates of a bad night in the lab
which, although non restorative, was no worse than usual.
These scores would not differ from scores of subjects who
typically slept well and also slept well in the lab.
The fact that subjects spent only one night in the
sleep laboratory creates a possible confound when
comparing the results of the current study with previous
research findings.

The first night in the sleep

laboratory has been shown to be associated with increased
sleep latency, decreased REM, and decreased stage 4 sleep
in normal individuals (Williams, Karacan, & Hursch, 1974).
This effect is lessened with subsequent nights spent in
the laboratory setting, and has resulted in the common
research practice of allowing an adaptation night in the
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sleep laboratory prior to data collection.

This proved

unfeasible in the present investigation due to limited
resources and need to maximize sample size.
Control subjects showed indications of a possible
mild first night effect in that they showed slightly less
REM sleep and slightly more stage 1 NREM sleep than
predicted by normative values for their age range
(Williams et al, 1974).

However, polysomnography results

indicated that control subjects' percentage of SWS, sleep
onset latency, and REM latency fell within expected ranges
despite the absence of an adaption night.

Thus, the

current data do not suggest the presence of a noteworthy
first night effect among control subjects. Due to the
lack of a relevant comparison group, it is difficult to
determine to what extent a first night effect may have
been present among high anxiety subjects.

However,

because the sleep of high and low anxiety subjects was
examined under identical experimental conditions the
absence of an adaption night is not problematic in
interpreting the current results.

Furthermore, previous

research findings regarding possible differences in
response to the first night spent in the sleep laboratory
for anxious subjects do not suggest that these individuals
show a more disrupted sleep pattern under novel conditions
than do normal control subjects.

Rather, available

research has suggested that clinical anxiety disorder
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samples (including PTSD and GAD) as well as non-clinical
samples of highly anxious subjects, show few changes from
the first to the second nights spent in a sleep laboratory
(Reynolds et al., 1983; Rosa et al., 1983; van Kammen et
al., 1990), and may actually show less habituation to the
lab environment than control subjects (van Kammen et al.,
1990).

These latter findings actually suggests a possible

second night confound when comparing anxious and normal
control subjects.

Thus, the possible presence of a first

night effect does not appear to represent a confound in
the interpretation of observed differences in
polysomnography variables between the high and low anxiety
groups in this study.

Summary and Implications
Results of the current investigation suggest that a
characteristic pattern of sleep disturbance is present in
highly anxious and worried individuals without co
morbidity and other confounds prevalent in the psychiatric
literature.

Objective polysomnographic findings indicate

that the sleep pattern of these individuals is consistent
with patterns documented in various anxiety disorder
samples, and is clearly distinct from that shown in
individuals with depressive disorders.

High anxiety

subjects were reliably identified as taking longer to fall
asleep, having less SWS, and showing more frequent stage 1

NREM episodes than low anxiety subjects.

Hie high anxiety

subject group also showed a significantly higher frequency
of arousals during the first half of the sleep period,
lower REM density, and a higher percentage of stage 1 NREM
sleep than the low anxiety subject group.
being statistically

In addition

different, this observed sleep

disruption in highly anxious subjects appears to represent
a clinically significant phenomenon.

In contrast to low

anxiety control subjects, who fell within normal ranges,
high anxiety subjects showed clinically significant sleep
onset insomnia and decreased sleep depth.

Although no

significant differences in mean EDS levels were present
during initial analyses, when SWS and REM variables were
entered as co-variates, results suggested that high
anxiety subjects showed relatively higher levels of EDS
activity than low anxiety subjects.
Disruption of sleep continuity and diminished SWS has
been documented in both anxious and depressed samples
(Benca et al., 1992).

However, the relation between

anxiety level and REM sleep variables observed during the
current investigation is distinct from patterns documented
in depressed satrples.

Current results revealed that

typical REM findings in depressed samples, which include
increased REM density, decreased REM latency and increased
REM percentage, are absent among individuals with "pure"
trait anxiety.

In fact, anxious and worried subjects
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showed less REM density than low anxiety control subjects,
findings opposite that of depressed subjects.
Decreased REM density in a group of subjects with
"pure" trait anxiety suggests that, although disruption of
sleep depth and continuity are not unique to anxiety
disorder populations, decreased SWS in anxious individuals
may be associated with a specific unique decrement in
sleep satiation.

In this context, it is particularly

noteworthy that the disruption of sleep in anxious
individuals in the current investigation appeared to occur
primarily during the initial portion of the sleep period,
a time which is characterized by a prominence of deep
sleep and low arousability in normal subjects.

This

portion of the sleep period has also been shown to be
significantly disrupted in clinical anxiety disorders, and
has been specifically associated with episodes of
nocturnal panic among PD subjects (Mellman & Uhde, 1989)
and traumatic nightmares among individuals diagnosed with
PTSD (Kramer & Kinney, 1988; van der Kolk et al., 1984).
This pattern suggests that the sleep of anxious
individuals may be particularly vulnerable to disruption
during early portions of the sleep period.

Thus, future

researchers should give specific attention to the initial
half of the sleep period.

In addition, further

investigation of this initial disruption may provide clues
regarding the relations between, and possible underlying
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mechanisms accounting for, objective polysomnography
findings and other symptoms, such as the hyper-vigilance
and psychophysiological insomnia frequently observed in
anxiety disorder populations.
In conclusion, results of the current investigation
indicate that anxiety and worry affect are associated with
disrupted sleep, independent of whether or not a diagnosed
anxiety disorder is present.

Current results indicate

that these factors are associated with a pattern very
similar to the sleep disruption observed in anxiety
disorders, independent of the presence of panic, previous
exposure to trauma, or a disease process per se.

The

relatively strong findings in the present study, in
comparison to the often inconsistent findings in clinical
anxiety disorder samples, suggest the need to concentrate
on controlling for co-morbidity and other confounds
frequently present in psychiatric subject samples.

In

addition to atterrpting to recruit relatively "clean"
clinical subjects, future investigations of sleep profiles
in psychiatric samples should avoid premature inclusion of
"mixed" diagnostic groups until such time as the specific
impact of trait anxiety upon sleep is understood.

Prior

to such understanding, future research which attempts to
clarify the possible causal links between reduced sleep
depth, disrupted sleep continuity, and anxiety/worry is
needed.

Replication of the reduced REM density finding

among high anxiety subjects, as well as the apparently
conplex relationship between anxiety level, EDS, SWS, REM
variables are also indicated in order to evaluate the
robustness of these findings and to establish to what
extent they may be specific to anxious and worried
individuals.
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APPENDIX B
PENN STATE WORRY QUESTIONNAIRE
Please mark the following items with the number (1-5)
which best indicates how well the statement describes you.
1
2
Not typical of
me at all
1.

3

4

5
Very typical
of me

If I do not have enough time to
do not worry about it.

do everything,I

2.

_____ My worries overwhelm me.

3.

_____ I do not tend to worry about things.

4.

_____ Many situations make me worry.

5.

_____ I know I should not worry about things, but I
just cannot help it.

6.

_____ When I am under pressure I worry a lot.

7.

_____ I am always worrying about something.

8._______ I find it easy to dismiss worrisome thoughts.
9.

_____ As soon as I finish one task, I start to worry
about everything else I have to do.

10. _____ I never worry about anything.
11. _____ When there is nothing more I can do about
concern, I do not worry about it anymore.

a

12. _____ I have been a worrier all of my life.
13. _____ I notice that I have been worrying about things.
14. _____ Once I start worrying, I cannot stop.
15. _____ I worry all of the time.
16. _____ I worry about projects until they are done.
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APPENDIX D
GENERAL INFORMED CONSENT

I hereby agree to participate in a research project
designed to study the sleep patterns of undergraduates.

I

understand that I will be asked to conplete questionnaires
and answer interview questions regarding my sleep
practices and mood, as well as my use of medications and
other substances which are known to influence sleep.

I

understand that my participation is voluntary and that I
am able to discontinue at any time without penalty.

I

further understand that my responses are confidential and
that my name will in no way be associated with the data
from the study.

I acknowledge that I have been given an

opportunity to ask questions regarding study and
understand that I may ask questions following the
completion of the study.

Your Name

Date

Researcher
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APPENDIX E
SCREENING INTERVIEW

Subject Number:
1. Previous Psychiatric History:
Have you ever had treatment of been hospitalized for
anxiety, depression, alcohol abuse or other emotional of
psychological problems? Y
N
If Yes to 1- When did these problems occur?

2. Panic Disorder:
Have you had times when you felt a sudden rush of intense
fear or discomfort in which you felt physical symptoms
such as shortness of breath, rapid heartbeat, trembling,
shaking, choking sensations, nausea, dizziness, or chest
pain; and/or were concerned that you would loose your mind
or die? Y
N
If Yes to 2
Have these feelings come "out of the blue" or
unexpectedly? I mean that they were not associated with a
particular situation and did not occur only while you were
ill or under the influence of a substance such as
caffeine. Y
N
How many times has this happened during the past month?

3.

Post-Traumatic Stress Disorder:
Have you experienced any extremely stressful, life
threatening or traumatic event such as serious physical
injury, assault, or seeing someone badly hurt or killed in
the past which still troubles you? Y
N
If Yes to 3
Do you reexperience this event through "flashback"
episodes or nightmares? Y
N.
Do you have intrusive thoughts about this event or
experience extreme anxiety in situations which remind you
of this event? Y
N

4. Social/Simple Phobia
4a. Are you unusually afraid of objects or situations the
average person is not disturbed by, such as heights, air
travel, or certain animals? Y N
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If yes to 4a
What objects or situations cause you
anxiety?_________________________________________________
Does this situation or object always make you very
anxious, and do you feel that your fear is excessive and
somewhat unreasonable? Y N
Do you avoid situations which may evoke this fear? Y

N

Do your fears and/or your avoidance associated with
this object or situation interfere with your daily life?
Y
N

4b. Are you uncomfortable doing certain things most
people do; like eating in a restaurant, using a public
restroom or speaking in a group of people because you are
afraid of embarrassing yourself? Y
N
If yes to 4b
What type of activities make you very
uncomfortable?
Does this discomfort interfere with your social life
or your ability to successfully perform your job or
schoolwork? Y N

5. Obsessive-Compulsive Disorder
5a. Are you bothered by recurrent thoughts, impulses, or
images that you can't stop from coming into your mind, and
which you feel are intrusive and senseless? This is not
the same as worrying about things that might happen.
I
mean things like a parent having repeated inpulses to kill
a loved child, or a religious persons having recurrent
blasphemous thoughts. Y N
If Yes to 5a-What kind of thoughts trouble
you?______________________________________________________
Do you try to ignore these thoughts or do something to
keep them out of your mind? Y
N
BBT- Do you often repeat some act over and over again that
doesn't seem to make sense and that you find distressing;
such as washing something over and over, counting things
or checking something repeatedly? Y
N
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If Yes to 5b-What are these actions? Are they related to
certain situations?

6. Major Depression:
Did you ever have a period of time, which lasted 2 weeks
or longer, when you felt depressed, sad, hopeless, or lost
interest in almost all of your usual activities? Y
N
If yes to 6
During this time did you notice changes in your
appetite, sleep or energy level? (if yes) What kinds of
changes did you notice?

How about changes in the way you felt about yourself
and the future such as feelings of low self esteem,
worthlessness, or hopelessness?
(if yes) Tell me about
these feelings___________________________________________
During this time did you notice any differences in
your ability to think or make decisions? (if yes) Tell me
about these changes
Have you been feeling this way nearly every day for
the last two weeks? Y
N

7. Dysthymia:
In the last two years have you felt down, blue, depressed
or have lost interest in things that usually give you
pleasure? Y N
If yes to 7
Have you felt this way more days than not for most of
the day during the past two years?
Y
N
What is the longest period during the past two years
in which you did not feel down or depressed? __________

8. Mania/Hypomania
Did you ever have a period of time, at least several days
long, when you felt extremely good or high- a feeling very
different from just being in a "good mood?" I am talking
about things like feeling that you possessed special
powers, having a decreased need for sleep, racing
thoughts, or feeling a pressure to keep talking such that
others were not able to keep up with you in conversation.
Y
N
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If yes to 8
Tell me about this time; did you do anything that
caused negative consequences such as unrestrained spending
or sexual activity?

Did you spend a lot more time than usual doing things
like studying, working, or social activities?

9. Psychosis:
Has there ever been a period of time when you had strange
experiences such as hearing voices or seeing visions which
other people could not see or hear? Y N
Have there ever been a time when people had trouble
understanding you because your speech was mixed up or
because you didn't make sense in the way that you were
talking? Y
N
Have you ever had the feeling that something odd was going
on around you, that people were doing things to test you
or antagonize you or hurt you so that you felt you had
constantly be on guard? Y
N
If yes to 10- When did this happen, explain

Did you have difficulty performing your usual activities,
maintaining your social relationships, and/or taking care
of yourself during this time?

10.
Substance Abuse
How much do you usually drink?^______________ ________
Do you take recreational or illegal drugs such as
marijuana, LSD, Cocaine? Y
N
If subject reports alcohol or drug use
How often and in what situations do you typically use
drugs/alcohol
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Has the use of drugs or alcohol ever interfered with
your school or work performance, or interfered in your
relationships with friends and family? Y
N If yes, how
has it interfered?
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SLEEP DISORDERS INVENTORY

William F. Waters, Ph.D.
Department of Psychology
Louisiana State University
and
Department o£ Neurology
Ochsner Clinic of Baton Rouge

and

Janes M. Tucci, M.D.
Department of Neurology
Ochsner Clinic of Baton Rouge

INSTRUCTIONS

111 The Sleep Disorders Inventory is a questionnaire that is designed to obtain
information that will assist in the description and diagnosis of a patient's sleep
disorder. It also provides information that is helpful in determining the causes and
the correct treatment of a patient's sleep disorder.
xxx Please answer these questions to the best of your ability. It is understood that some
of your answers will be approximations, not exact. Such estimates are acceptable.
Also, a few of the questions may require information from a person who has observed
your sleep. If you have access tosuch information, feel free to use it.
1X1 If you are asked to give
a YES NO answer, andyou are not certain of
your response,
give the answer that is closest to the truth as best you can determine. If you are
asked to give a numerical ansvrer, such as the number of minutes it takes you to fall
asleep, and you are not certain, give an approximate answer that is closest to the
truth as best you can determine.
xxx

Please answer ALL of the
questions. If a YESNO item does not apply
to you,answer
NO. If you encounter an item that calls for a numerical response and it does not
apply to you, or you cannot give an estimate, the number 0 will Indicate that it does
not apply or that you cannot estimate.

xxx Before conpleting the SDI, please provide the following information:
NAJiE: ___________________________________________

DATE: ____________________ __

SOCIAL SECURITY NUMBER: _________________________

CLINIC NUMBER: ,
______________

THE SLEEP DISORDERS INVENTORY BEGINS ON THE NEXT PAGE.
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* Please CIRCLE the appropriate response for each of the YES_NO questions. Please FILL
THE BLANK with the correct number for each question that is
followed by ablank.

1.

IN

Do you have difficulty falling asleep at night?............................... YES__ NO
*** If your answer Is NO, go to the next item. If your answer is YES, go to (a).
(a) How many NIGHTS per WEEK do you usually have difficulty?................... .......
(b) On nights when you have difficulty falling asleep, how many MINUTES does 1t
usually take you to fall asleep?........................................... .......
(c) On nights when you have this problem, how many HOURS do you sleep?......... .......

2.

How many MINUTES does it usually take you to fall asleep on your BEST nights?..._______

3.

Oo you wake up during the night and have difficulty falling back to sleep..... YES__ NO
*** If your answer is NO, go to the next Item. If your answer is YES, go to (a).
(a) About how many NIGHTS does this happen each WEEK?.......................... .......
(b) On the average, how many TIMES do you wake up 9ach NIGHT?.................. .......
(c) How many MINUTES does it take you to fall asleep after awakening?.......... .......
(d) On nights when you have this problem, how many HOURS do you sleep?......... .......

•4.

Do you wake up 1n the morning before your scheduled wake time, and are unable to
return to sleep?________________________________________________________________ YES__NO

*** If your answer is NO, go to the next Item. If your answer is YES, go to (a).
(a) How many TIMES per WEEK do you have this problem?.......................... .......
(b ) On nights when you have this problem, how many HOURS do you sleep?......... .......
Do you wake up during the night frequently, but fall asleep soon afterwards?....YES

NO

*** If your answer is NO, go to the next Item. If your answer is YES, go to (a).
(a)

How many TIMES a NIGHT do you wake up?.................................... .......

fb) How many NIGHTS each WEEK do you have this problem?........................ .......
S.

How many HOURS do you sleep on your BEST nights?......................................

T.

Does your bed partner disturb your sleep at night?.............................. YES_NO
*** If your answer is NO, go to the next item. If your answer is YES, go to (a).
(a)

Is this a reason for your insomnia SOME of the time?....................... YES_NO

<b) Is this the reason for your insomnia MOST of the time?......................YES_NO
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8.

Is your sleep disturbed by environmental factors such as traffic, neighbors or
family members?

YES

NO

*** If your answer is NO, go to the next Item. If your answer 1s YES, go to (a).
(a) Is this a reason for your Insomnia SOME of the time?........................ YES_NO
(b) Is this the reason for your Insomnia MOST of the time?...................... YES_NO
9.

Is your bedroom dark enough for sleep at night?..................................YES_NO
*»* If your answer 1s YES, go to the next item. If your answer 1s NO, go to (a).
(a) Is this a reason for your Insomnia SOME of the time?........................ YES_NO
(b) Is this the reason for your Insomnia MOST of the time?...................... YES_NO

10. Is your bedroom temperature comfortable enough for sleep at night?...............YES_NO
*** If your answer 1s YES, go to the next Item. If your answer is NO, go to (a).
(a) Is this a reason for your Insomnia SOME of the time?........................ YES_NO
(b) Is this the reason for your Insomnia MOST of the time?...................... YES NO
11. How many NIGHTMARES have you had in the last MONTH?............................ .......
(a) How many TIMES in the last MONTH have nightmares awakened you?............. .......
(b) How INTENSE are your nightmares (Rate 1,2,3,4, or 5; where 1-mlld,
3-frightening, 5=terr1fy1ng)?.............................................. .......
12.

Do you often move vigorously during your sleep, especially while
dreaming,
and sometimes even hurt your partner by accident, or fall out of bed?............YES_NO

13. Have you ever awakened from a deep sleep sweating, your heart beating fast or
pounding, with a feeling of fear but with no memory of a dream?_________________ YES_NO
*** If ycur answer 1s NO, go to the next item. If your answer is YES, go to (a).
(.a) How many TIMES in the last MONTH has this happened?........................ .......
(b)

14.

How INTENSE was this experience (Rate 1,2,3,4, or 5; where 1-mi Id,
3-frightening, 5-terrifying)?.............................................. .......

How many NIGHTS per MONTH do you:
Snore loudly
Thrash about while asleep (but are not dreaming)
Gasp or snort while asleep
Stop breathing while asleep
Wake up in the night and feel unable to breathe

'■S. Do you often awaken with headaches?_____________________________________________YES__NO
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16. Do you sleep

enough hours but have trouble waking up, feeling unrefreshed?______ YES_NO

17. Do you sleep enough hours but fall asleep Involuntarily during the day, but
only when relatively unstimulated?______________________________________________YES__NO
18. Do you sleep enough hours but fall asleep Involuntarily during the day, even
when doing something very Important, like driving?.............................. YES_NO
19. Do you sleep
20.

enough hours but still have trouble functioning during the day?____ YES_NO

Do you ever wake up because your legs jerk repeatedly while you are asleep?.....YES_NO
a **

Answer only if YES: How many NIGHTS per MONTH does this occur?............ .......

21. Do your legs ever feel restless or odd after you go to bed at night, and it
keeps you awake?_________________________________________________________________YES_NO
Answer Only if Y'ES: How many nIuhts per MONTH does this occur? ............ .......
22.

Do you walk in your sleep?______________________________________________________ YES_NO

*** If your answer is NO, go to the next item. If your answer is YES, go to (a).
(a) How many TIMES a MONTH does this happen?................................... .......
(b) About how many MINUTES pass by while you are sleepwalking?................. .......
23.

Do you talk in your sleep?....................................................... YES_NO

24.

Do you grind your teeth 1n your sleep?...........................................YES_NO

25.

Do you suddenly sit up in bed. still asleep, then lie down agsin?............... YES_NO

26.

Do you ever wet your bed while asleep?.......................................... YES_NO

27.

Do you experience extreme weakness in any of your muscles or even col lapse,when
vou are excited. ngrynijs> emotional, or laughing?............................... YES_NO

28. Do you often see things that are not there, as you are falling asleep or
waking up?....................................................................... YES_NO
?9. no you often feel paralyzed while falling aslsep or waking up?.................. yes_No
30.

Do you ever work the night shift, for example 11 p.m.-7 a.m.?................... YES_NO
*** Answer only if YES: How many NIGHTS per MONTH?............................ .......

31. Does lack of sleep often cause you to fall asleep at inappropriate times or in
the wrong place during the day?................................................. YES_NO
32.

Does lack of sleep often cause you to have troublefunctioning during the day?..YES__ NO

33.

Do you ever bring work home and do 1t after 8:00 p.m.?......................... YES_NO
*** Answer only 1f YES; How many NIGHTS per WEEK?............................. .......

34. On weekends or your days off, do you sleep more than an hour later than your
usual wake up time?.............................................................. YES_NO
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35. How many TIMES per NIGHT do you wake up to use the bathroom?................... .......
36. How many NIGHTS per WEEK do you wake up with Indigestion or heartburn?...............
37. Doyou eat your last meal or a large snack within 3 hours of bedtime?............ YES_NO
38. Are you on a weight loss program?............................................... YES_NO
39. Do

you engage in some kind of regular

physical exercise?.................. YES_NO

40. Do

you exercise at night, within four

hours of bedtime?................... YES_NO

41. How many GLASSES (bottles/cans) of alcoholic drink do you have each DAY?....... .......
42. How many NIGHTS each MONTH do you use alcohol to aid sleep?...........................
43. How many CUPS or GLASSES of caffeinated beverages do you drink 1n a DAY?....... .......
44. How many DAYS a WEEK do you drink caffeinated beverages after 6 p.m.?.......... .......
46. How many CIGARETTES a DAY do you smoke?........................................ .......
46. Do you take any medications that contain caffeine or stimulants, such as allergy
medications, nasal decongestants, or pain killers?.............................. YES_NO
**» Answer only 1f YES: How many MINUTES before trying to sleep do you take it?_______
47. Is

your sleep problem sometimes worse

than other times?................... YES_NO

*** If your answer is NO, go to the next item. If your answer 1s YES, go to (a).
(a) Is it worse when you are under stress?...................................... YES_NO
(b) Is it better when

you sleep away from home?................................ YES_NO

48. Was the onset of yoursleep problem related to any

specificevent?............... YES_NO

*** If your answer is NO, go to the next item. If your answer 1s YES, go to (a).
(a) Were you under unusual stress at the onset of your sleep problem?........... YES_NO
(b) Were you very ill or 1n pain at the onset of your sleep problem?............ YES_NO
49. Is your sleep problem caused or made worse by physical discomfort or pain:
Never: ____ Rarely;_____ Sometimes;

Often; ____ Most or all of the time.

50.

Wnen you try to sleep, is it hard for you to turn off your mind?................ YES_NO

51.

When youhave sleep problems, do you:
(a) Go to bed earlier on some nights to make up lost sleep?..................... YES_NO
(b) Wake up later on some
(c) Get up out of bed

mornings to make up lost

sleep?...................YES_NO

and watch television, read, catch uponwork, cr eat?

YES___ NO
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(d)

Take naps during normal waking hours?..................................... YES

NO

*** If your answer is NO, go to the next item. If your answer Is YES, go to (1).
(1) How many TIMES per WEEK do you take naps?................................ _ _ _ _ _
(2) How many MINUTES are your naps, on average?.............................. .......
(3) Oo you awaken from your naps refreshed?.................................. YES

NO

52.

Have you been under more stress than usual recently?.......................... YES

NO

£3.

A.-s you ths kind of person who tends to worry a lot?.......................... YES_NO

54.

Does your sleep problem affect your mood during the day?...................... YES

NO

55. Have you ever been treated or hospitalized for mental, emotional, drug, or
alcohol problems?.............................................................. YES

NO

56.

NO

Have you ever had any convulsions or significant headInjury?.................. YES

57. How long have you had your sleep problem?

Years

Months

Weeks

58. Have you previously received non-drug treatment for sleep problems?............ YES__NO
59. Have you recently taken any prescription or over-the-counter medication for
sleep problems?........................................................ .

>YES

*** If your answer 1s NO, go to the next Item. If your answer is YES, go to (a).
(a) How many NIGHTS a WEEK do you usually take this medication?................ .....
(b) How many MONTHS have you been taking sleep medication?..................... .....
60.

Please list which medications you are now taking and the condition for which each is
being taken. Include over-the-counter medications.
MEDICATION

CONDITION

MEDICATION

CONDITION

1

5

•>

6

3

7

4

8

Please list any medications you have recently stopped taking and the condition for
which each was being taken. Include over-the-■counter medications.

1

4

2

5

3

6
***

CONDITION

MEDICATION

CONDITION

MEDICATION

THANK YOU FOR COMPLETING THIS INVENTORY

***

NO

APPENDIX G
POLYSOMNOGRAPHY DESCRIPTION FOR SUBJECTS
We ask that you report to the hospital approximately
two hours before your normal bedtime. There you will find
a comfortable bedroom setting in which to spend the night.
Each subject will be provided with a private bedroom and
bathroom to assure privacy. Subjects will provide their
own sleeping attire, and should plan to bring these items
with them to the hospital. Please refrain from napping or
consumption of alcoholic beverages or medications during
the day on which you are scheduled to participate in the
sleep study. In addition, do not consume foods or
beverages containing caffeine or other stimulants after 6
pm on the evening of the polysomnogram.
During the hookup procedure small gold cups will be
placed in various positions on your head, face, and legs.
This is a painless and harmless procedure, using a paste
that easily washes off. You will be asked to sleep in the
bedroom with the electrodes attached to you. The
experience of many years of such recordings indicates that
individuals have no difficulty sleeping with these
recording elements attached to their skin. We will be
recording electrical activity of your brain, movement of
your eyes, and activity of your sweat glands and muscles.
A research assistant in a nearby room will be
watching a television monitor connected to a video camera
in the room in which you are sleeping. The purpose of
this camera is to determine the position in which you are
sleeping during the night. The research assistant will
also be monitoring the room over an intercom system.
Therefore, you can be heard easily in the event that you
should need assistance during the night.
You will be awakened for the day at 6:30 am.
Recording equipment will be removed and you will be asked
to corrplete a brief questionnaire asking about how well
you slept the night before. Your participation will then
be complete, and you will be able to leave the lab at
approximately 6:45.
I understand the procedures involved in
polysomnography, and agree to participate in this portion
of the research study. I will arrive at the Baton Rouge
General Medical Center
at______________pm

Signature of Subject
Assistant

on the following date________________ .

Signature of Research
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APPENDIX H
INFORMED CONSENT FOR POLYSOMNOGRAPHY
I, _________________
_____ _________ , freely and
willingly consent to participate m a research project
investigating sleep patterns in individuals with high
versus low trait anxiety. As a research subject, I will
complete psychometric screening measures and participate
in one night of polysomnography.
I understand that this procedure is non-invasive and
are no foreseeable risks associated with polysomnography.
I understand that the results of this study may
potentially assist in the further understanding of the
sleep disturbances which often accompany anxiety states.
I understand that I may chose to decline to
participate in this study at any time without any penalty
or jeopardizing, in any way, any future medical treatment
in this institution. Finally, I understand that my
privacy will be protected and my name will not be used in
any manner whatsoever in subsequent use of the results of
this study. I understand that results of both
polysomnography and psychometric testing will remain
strictly confidential; and that I will be assigned a
subject number which will be used in subsequent data
analysis in the place of my name.
I have read and thoroughly understand this consent
form and acknowledge that I have been given a copy of the
consent form for my own use.

Subj ect1s Name

Date

Experimenter

Date

APPENDIX I
POLYSOMNOGRAPHY HOOK-UP PROCEEDURES
Subjects were allowed to ask any questions prior to
electrode placement.

The subject then changed into his/her

sleeping apparel and sat in a chair placed at bedside for
electrode placement.

Electrodes were placed on the

subject's scalp, face and hand.

All EEG, EMG, and EOG

electrode placements were based on the system developed at
Stanford University School of Medicine and described in
Carskadon's widely used manual A Manual for Polysomnography
(PSG) Technicians (Carskadon, 1980).
Electroencephalogram (EEG) electrode placements were
based on a simplified version of the 10-20 system developed
by the International Federation of Societies of
Electroencephalography and Clinical Neurology (Carskadon,
1980) .

This system is based on measurements from four

standard points on the head:

(1) nasion (depression at

bridge of the nose), (2) inion (the protrusion of bone in
the back of the head), and (3) left and right pre-auricular
points (notches just in front and above the lobes of the
ears (Hassett, 1978).

The following notations are used in

designation of electrode placements:

F (frontal), C

(central), P (parietal), T (temporal) , 0 (occipital), Fp
(frontal pole), and z (midline) .

In addition, odd

subscripts refer to the left side of the skull and even
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subscripts refer to the right side of the head when
referring the electrode placement sites.
The following procedures were used to determine exact
electrode placement on individual subjects.

The distance

between the nasion and inion was be measured using a
flexible tape.

A grease pencil was used to mark the center

point on the skull between these two reference points (Cz).
Marks were also placed perpendicular to the tape at
distance 10% up from the inion (Oz) and nasion (Fpz).
These marks served as landmarks for other measurements.
The distance between the left and right pre-auricular
points was then measured by placing the tape along the
first Cz mark.

A mark was placed perpendicular to the tape

at the center point on the skull.

The intersection of the

first and second mark indicated the precise location of Cz
(the middle of the top of the head.

Marks were also placed

10% up from the left and right pre-auricular points (T3 and
T4 respectively) . These marks also served as landmarks for
other measurements.
The distance between T3 and Cz was measured by placing
the tape on the transverse plane through Cz.

A mark was

then placed perpendicular to the tape at the center point
(C3).

This same series of measurements was repeated (using

points T4 and Cz) in determining the location of C4.

The

measuring tape was then placed around the circumference of
the head passing through Fpz, T3, Oz and T4.

Marks were

placed perpendicular to the tape at distances of 5% of the
circumference to the left and right of Fpz and Oz.

These

points represented Fpl, Fp2, 01 and 02 respectively.

The

second mark, delineating the exact location of C3, was made
by placing the measuring tape from 01 to Fpl through the
existing mark for C 3 . A mark was placed perpendicular to
the tape at the center point, thus forming an intersection
with the previous C3 mark which pinpoints the exact
location of C3.

The same procedure was used on the right

side of the skull to determine the exact placement of C4.
The second marks for 01 and 02 were made by continuing the
mark from Oz to intersect with the original 01 and 02
marks.
Grass electrodes (gold plated, 8mm diameter) were
placed at the intersection of marks for Fpz, C3, C4, Cz,
01, and 02.

The electrode of Fpz served as a ground; it

was not referenced to another electrode and did not serve
as a recording channel.

The electrode for C3 was

referenced to an electrode placed on the mastoid process
behind the right ear (A2). The electrode for C4 was
referenced to an electrode placed on the mastoid process
behind the left ear (Al). The C3 and C4 electrodes, along
with their respective reference points, served as backup
recording channels for each other.

The electrode for Cz

was referenced to both Al and A2 electrodes.
electrode was referenced to the Cz electrode.

The 02
The
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electrode at 01 served as a backup in case the 02 electrode
lost contact with the scalp during the course of the
recording.

The signals from electrodes at C3, Cz, C4, 01,

and 02 (along with their respective reference electrodes)
were fed into a Grass Electroencephalograph Model 8-16 D,
with the sensitivity set at 5 microvolts per mm and the
high frequency and low frequency filters set at 35 Hz and
.3 Hz respectively.
Continuous eye movement recordings (EOG's) were also
made with Grass electrodes (gold plated, 8mm diameter)
which were attached one centimeter above the right outer
canthus (outer c o m e r of the eye) and one centimeter below
the left outer canthus.

The electrodes for both the right

eye (EOG-right) and left eye (EOG-left) were referenced to
the electrode placed on the left mastoid process (Al) .
Sensitivities for these recording channels were set at 15
microvolts per mm.

The high frequency filters were set at

35 Hz and low frequency filter at .3 Hz.
Electromyogram (EMG) muscle potential recordings were
also recorded continuously using Grass electrodes (gold
plated, 8mm diameter) which were attached to muscle areas
on (mental muscles) and beneath (submental muscles) the
chin and on both legs (right and left anterior tibialis
muscles) .

Sensitivity for the channel recording

mental/submental EMG was set at 2 microvolts per mm, with
the high frequency filter set at 70

Hz and the low
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frequency filter set at 5 Hz.

ENG recordings taken from

the anterior tibialis muscles of each leg were taken from
two electrode sites placed 4 cm apart on each leg.
Sensitivities for these recordings were set at 7 microvolts
per mm, the high frequency filter was also set to 70 Hz and
the low frequency filter to 5 Hz for these channels.
Skin potential was used as a measure of electrodermal
activity, and was recorded with Med Associates silversilver chloride electrodes (20 mm diameter) taped to the
palmar surface of the distal phalange of the ring finger of
the right hand and to the medial surface at the elbow of
the right arm.

This channel was recorded using a

sensitivity setting of 7 microvolts per mm, with the high
frequency filter set to 15 Hz and the low frequency filter
set to .1 Hz.
In addition, airflow was monitored via an oral/nasal
thermistor in order to rule out the presence of sleep
apnea.

The sensitivity for this recording channel was set

at 7 microvolts per mm and high and low frequency filters
were set at 15 Hz and .1 Hz respectively.
All electrode sites were prepared by lightly abrading
the skin surface with Omni Prep, a standard hypo-allergenic
skin cleanser.

Electrodes for EEG and chin EMG were

affixed to the skin by placing a one-inch gauze square
which has been soaked in collodion (a standard adhesive)
over the electrode and drying the gauze using an air
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compressor with an electrode applicator attached.

These

electrodes were removed using collodion remover, a standard
hypo-allergenic adhesive remover, in the morning.
Electrodes for EOG and leg EMG were taped to the skin.

All

electrodes were filled through a hole on their top surface
with Beckman Electrode Electrolyte using a syringe with a
blunt needle.

Electrodes for skin potential were attached

to the skin using a double sided adhesive collar, and were
filled with Beckman Electrode Electrolyte prior to
attachment to the skin.
After the electrodes were placed on the subject, they
were attached to a terminal box.

The inpedance was then

checked by attaching the terminal box to an impedance meter
which has been calibrated to 10 kilohms.

The impedance of

EEG, EMG, and EOG channels were checked to ensure that all
impedance readings were below 10 kilohms.

If the impedance

is greater than 10 kilohms for any electrode, that
electrode was removed from the subject, the site was
cleaned again, and the electrode re-attached.

Once all

impedance readings are below 10 kilohms, the terminal box
was connected to the Grass Electroencephalograph Model 8-16
D.

Paper speed for all recordings was 10 mm per second, at

which one page of polygraph paper was recorded in 30
seconds of electrophysiological activity (one epoch).
After the terminal box was connected to the
electroencephalograph, recording channels were checked.
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The subject was then asked to move his/her eyes, bite down,
move his/her legs, hold his/her breath for ten seconds, and
to close his/her eyes and relax so that EEG, EMG and EOG
channels could be checked.

When all channels were

functioning properly, the technician answered any questions
which the subject had at this time.

The lights were then

turned off and the subject allowed to sleep.

APPENDIX J
SLEEP PROTOCOL MONTAGE

Channel

Sensitivity

HFL (Hz)

LLF (Hz)

Montacre
C3-A2
C4-A1
c z -a i /a :
02-CZ

Channels 1-4
are EEG
channels

1
2
3
4

5
5
5
5

uv/mm
uv/mm
uv/mm
uv/mm

35
35
35
35

.3
.3
.3
.3

Chin EMG

5

2 uv/mm

70

5

F3-FZ

EOG Left
EOG Right

6
7

15 uv/mm
15 uv/mm

15
15

.1
.1

Fpl-Al
Fp2-A2

Oral/Nasal
Thermistor

8

7 uv/mm

15

.1

T3-T4

Skin
Response

9

7 uv/mm

15

.1

36-37

Leg EMG (R)
Leg EMG (L)

10
11

7 uv/mm
7 uv/mm

70
70

5
5

26-27
28-29

Paper speed is 10 mm/second
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APPENDIX K
DAILY SLEEP DIARY
NAME: _______________________

DATE:_________________

PLEASE RESPOND TO THE FOLLOWING QUESTIONS.
1. About what time did you first try to fall asleep last
night? __________
2. Approximately how many minutes did it take you to fall
asleep? _________
3. Please record the approximate times you awoke last
night, and below that, how long it took you to get back to
sleep.
min

min

mm

mm

mm

4. When did you awaken for the day this moming?_
5. How difficult was it for you to fall asleep last night?
1
2
3
4
5
Not Very
Extremely
Difficult
Difficult
6. How rested do you feel this morning?
1
2
3
Very Rested

4

5
Poorly Rested

7. Rate the quality of last night's sleep.
1
2
3
4
Excellent

5
Very Poor

8. What was your level of physical tension when you went
to bed last night?
1
2
3
4
5
Extremely
Extremely
Relaxed
Tense
9. Rate your level of mental activity when you went to bed
last night.
1
2
3
4
5
Very Quiet
Very Active
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APPENDIX L
MICRO-AROUSAL SCORING PROCEEDURES

Scoring of micro-arousals will follow the recent
standardized guidelines described by Bonnet et al. (1992).
A micro-arousal will be defined as an abrupt shift in EEG
frequency, which may include theta, alpha, and/or
frequencies greater than 16 Hz but not spindles, subject
to the following rules and conditions:

(1) Subjects must

be asleep, defined as 10 continuous seconds or more of the
indications of any stage of sleep before an arousal can be
scored.

Arousal scoring is independent of Rechtschaffen

and Kales epoch scoring (i.e. an arousal can be scored in
an epoch of recording which would be classifies as wake by
Rechtschaffen and Kales criteria) .

(2) A minimum of 10

continuous seconds of intervening sleep is necessary
between independent arousals.

(3) The EEG frequency shift

must be 3 seconds or greater in duration to be scored as
an arousal.

(4) Arousals in NREM sleep may occur without

concurrent increases in chin EMG amplitude.

(5) Arousals

in are scored in REM sleep only when accompanied by
concurrent increases in chin EMG amplitude.

(6) Arousals

cannot be scored based on changes in chin EMG amplitude
alone.

(7) Artifacts, K complexes, or delta waves are not

scored as arousals unless accompanied by an EEG frequency
shift of at least 3 seconds duration.
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If such activity

precedes an EEG frequency shift, it is not included in
reaching the 3-second duration criteria.

When occurring

within the EEG frequency shift, such artifacts are
included in meeting duration criteria.

(8) The occurrence

of pen blocking artifact is considered an arousal only if
an EEG arousal pattern is contiguous.

In this event, the

pen blocking artifact may be included in meeting the
duration criteria.

(9) Non-concurrent, but contiguous,

EEG and EMG changes which were individually less than 3
seconds, but together were greater than 3 seconds in
duration, are not scored as arousals.

(10)

Intrusion of

alpha activity of less than 3 seconds into NREM sleep at a
rate greater than one burst per 10 seconds is not scored
as an EEG arousal.

(11). Transitions from one stage of

sleep to another are not sufficient of themselves to be
scored as EEG arousals unless they meet the criteria
previously outlined.
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